Albemarle (ALB) 10-Q 2 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Oct. 31, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	1-12658
Entity Registrant Name	ALBEMARLE CORPORATION
Entity Incorporation, State or Country Code	VA
Entity Tax Identification Number	54-1692118
Entity Address, Address Line One	4250 Congress Street, Suite 900
Entity Address, City or Town	Charlotte
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28209
City Area Code	(980)
Local Phone Number	299-5700
Title of each class	COMMON STOCK, $.01 Par Value
Trading Symbol	ALB
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		117,152,794
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000915913
Current Fiscal Year End Date	--12-31

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Net sales	$ 2,091,805	$ 830,566	$ 4,699,126	$ 2,433,753
Cost of goods sold	1,047,991	581,293	2,625,858	1,672,376
Gross profit	1,043,814	249,273	2,073,268	761,377
Selling, general and administrative expenses	134,479	103,477	375,989	318,180
Research and development expenses	18,358	13,289	51,827	41,901
(Gain) loss on sale of business/interest in properties	0	984	8,400	(428,424)
Operating profit	890,977	131,523	1,637,052	829,720
Interest and financing expenses	(29,691)	(5,136)	(98,934)	(56,170)
Other income (expense), net	7,974	(643,196)	32,237	(631,870)
Income (loss) before income taxes and equity in net income of unconsolidated investments	869,260	(516,809)	1,570,355	141,680
Income tax expense (benefit)	196,938	(114,670)	366,486	14,422
Income (loss) before equity in net income of unconsolidated investments	672,322	(402,139)	1,203,869	127,258
Equity in net income of unconsolidated investments (net of tax)	258,884	27,706	449,476	62,215
Net income (loss)	931,206	(374,433)	1,653,345	189,473
Net income attributable to noncontrolling interests	(33,991)	(18,348)	(95,974)	(61,977)
Net income (loss) attributable to Albemarle Corporation	$ 897,215	$ (392,781)	$ 1,557,371	$ 127,496
Basic earnings per share (in dollars per share)	$ 7.66	$ (3.36)	$ 13.30	$ 1.10
Diluted earnings per share (in dollars per share)	$ 7.61	$ (3.36)	$ 13.23	$ 1.10
Weighted-average common shares outstanding - basic (in shares)	117,136	116,965	117,106	115,455
Weighted-average common shares outstanding - diluted (in shares)	117,869	116,965	117,749	116,140

Consolidated Statements of Comp

Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 931,206	$ (374,433)	$ 1,653,345	$ 189,473
Other comprehensive (loss) income, net of tax:
Foreign currency translation and other	(200,520)	(39,274)	(324,230)	(46,852)
Net investment hedge	0	0	0	5,110
Cash flow hedge	(9,652)	214	(8,144)	(563)
Interest rate swap	0	651	7,399	1,951
Total other comprehensive loss, net of tax	(210,172)	(38,409)	(324,975)	(40,354)
Comprehensive income (loss)	721,034	(412,842)	1,328,370	149,119
Comprehensive income attributable to noncontrolling interests	(33,990)	(18,374)	(95,858)	(61,927)
Comprehensive income (loss) attributable to Albemarle Corporation	$ 687,044	$ (431,216)	$ 1,232,512	$ 87,192

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,382,803	$ 439,272
Trade accounts receivable, less allowance for doubtful accounts (2022 – $2,495; 2021 – $2,559)	1,035,117	556,922
Other accounts receivable	135,709	66,184
Inventories	1,614,299	798,620
Other current assets	129,043	132,683
Total current assets	4,296,971	1,993,681
Property, plant and equipment, at cost	8,713,771	8,074,746
Less accumulated depreciation and amortization	2,288,664	2,165,130
Net property, plant and equipment	6,425,107	5,909,616
Investments	1,158,535	912,008
Other assets	217,057	252,239
Goodwill	1,467,848	1,597,627
Other intangibles, net of amortization	262,984	308,947
Total assets	13,828,502	10,974,118
Current liabilities:
Accounts payable	1,651,866	647,986
Accrued expenses	385,327	763,293
Current portion of long-term debt	251,216	389,920
Dividends payable	46,098	45,469
Income taxes payable	153,444	27,667
Total current liabilities	2,487,951	1,874,335
Long-term debt	3,118,753	2,004,319
Postretirement benefits	42,681	43,693
Pension benefits	187,498	229,187
Other noncurrent liabilities	597,980	663,698
Deferred income taxes	429,012	353,279
Commitments and contingencies (Note 10)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 117,145 in 2022 and 117,015 in 2021	1,171	1,170
Additional paid-in capital	2,933,659	2,920,007
Accumulated other comprehensive loss	(717,309)	(392,450)
Retained earnings	4,515,115	3,096,539
Total Albemarle Corporation shareholders’ equity	6,732,636	5,625,266
Noncontrolling interests	231,991	180,341
Total equity	6,964,627	5,805,607
Total liabilities and equity	$ 13,828,502	$ 10,974,118

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 2,495	$ 2,559
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, issued (in shares)	117,145	117,015
Common stock, outstanding (in shares)	117,145	117,015

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Total Albemarle Shareholders' Equity	Non-controlling Interests
Beginning Balance (in shares) at Dec. 31, 2020		106,842,369
Beginning Balance at Dec. 31, 2020	$ 4,468,594	$ 1,069	$ 1,438,038	$ (326,132)	$ 3,155,252	$ 4,268,227	$ 200,367
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	189,473				127,496	127,496	61,977
Other comprehensive (loss) income	(40,354)			(40,304)		(40,304)	(50)
Cash dividends declared	(197,927)				(136,749)	(136,749)	(61,178)
Stock-based compensation	13,981		13,981			13,981
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	(888)		(888)			(888)
Exercise of stock options (in shares)		263,875
Exercise of stock options	16,220	$ 3	16,217			16,220
Issuance of common stock, net (in shares)		9,918,778
Issuance of common stock, net	1,453,888	$ 99	1,453,789			1,453,888
Shares withheld for withholding taxes associated with common stock issuances (in shares)		(48,704)
Withholding taxes paid on stock-based compensation award distributions	(7,755)	$ (1)	(7,754)			(7,755)
Ending Balance (in shares) at Sep. 30, 2021		116,976,318
Ending Balance at Sep. 30, 2021	5,895,232	$ 1,170	2,913,383	(366,436)	3,145,999	5,694,116	201,116
Beginning Balance (in shares) at Jun. 30, 2021		116,944,511
Beginning Balance at Jun. 30, 2021	6,365,771	$ 1,169	2,907,981	(328,001)	3,584,400	6,165,549	200,222
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	(374,433)				(392,781)	(392,781)	18,348
Other comprehensive (loss) income	(38,409)			(38,435)		(38,435)	26
Cash dividends declared	(63,100)				(45,620)	(45,620)	(17,480)
Stock-based compensation	4,203		4,203			4,203
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	23		23			23
Exercise of stock options (in shares)		22,226
Exercise of stock options	1,885	$ 1	1,884			1,885
Issuance of common stock, net (in shares)		12,688
Shares withheld for withholding taxes associated with common stock issuances (in shares)		(3,107)
Withholding taxes paid on stock-based compensation award distributions	(708)		(708)			(708)
Ending Balance (in shares) at Sep. 30, 2021		116,976,318
Ending Balance at Sep. 30, 2021	5,895,232	$ 1,170	2,913,383	(366,436)	3,145,999	5,694,116	201,116
Beginning Balance (in shares) at Dec. 31, 2021		117,015,333
Beginning Balance at Dec. 31, 2021	5,805,607	$ 1,170	2,920,007	(392,450)	3,096,539	5,625,266	180,341
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,653,345				1,557,371	1,557,371	95,974
Other comprehensive (loss) income	(324,975)			(324,859)		(324,859)	(116)
Cash dividends declared	(183,003)				(138,795)	(138,795)	(44,208)
Stock-based compensation	24,213		24,213			24,213
Exercise of stock options (in shares)		16,166
Exercise of stock options	1,203		1,203			1,203
Issuance of common stock, net (in shares)		176,293
Issuance of common stock, net	387	$ 2	385			387
Shares withheld for withholding taxes associated with common stock issuances (in shares)		(62,428)
Withholding taxes paid on stock-based compensation award distributions	(12,150)	$ (1)	(12,149)			(12,150)
Ending Balance (in shares) at Sep. 30, 2022		117,145,364
Ending Balance at Sep. 30, 2022	6,964,627	$ 1,171	2,933,659	(717,309)	4,515,115	6,732,636	231,991
Beginning Balance (in shares) at Jun. 30, 2022		117,121,748
Beginning Balance at Jun. 30, 2022	6,300,975	$ 1,171	2,927,086	(507,138)	3,664,172	6,085,291	215,684
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	931,206				897,215	897,215	33,991
Other comprehensive (loss) income	(210,172)			(210,171)		(210,171)	(1)
Cash dividends declared	(63,955)				(46,272)	(46,272)	(17,683)
Stock-based compensation	7,405		7,405			7,405
Exercise of stock options (in shares)		8,377
Exercise of stock options	735		735			735
Issuance of common stock, net (in shares)		21,597
Shares withheld for withholding taxes associated with common stock issuances (in shares)		(6,358)
Withholding taxes paid on stock-based compensation award distributions	(1,567)		(1,567)			(1,567)
Ending Balance (in shares) at Sep. 30, 2022		117,145,364
Ending Balance at Sep. 30, 2022	$ 6,964,627	$ 1,171	$ 2,933,659	$ (717,309)	$ 4,515,115	$ 6,732,636	$ 231,991

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Equity (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Financial Position [Abstract]
Cash dividends declared (in dollars per share)	$ 0.395	$ 0.39	$ 1.19	$ 1.17

Condensed Consolidated Statemen

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Statement of Cash Flows [Abstract]
Cash and cash equivalents at beginning of year	$ 439,272	$ 746,724
Cash flows from operating activities:
Net income	1,653,345	189,473
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization	215,280	185,765
(Gain) loss on sale of business/interest in properties	8,400	(428,424)
Stock-based compensation and other	24,649	14,668
Equity in net income of unconsolidated investments (net of tax)	(449,476)	(62,215)
Dividends received from unconsolidated investments and nonmarketable securities	350,895	43,374
Pension and postretirement benefit	(12,299)	(12,451)
Pension and postretirement contributions	(10,929)	(24,145)
Unrealized gain on investments in marketable securities	3,864	(3,912)
Loss on early extinguishment of debt	19,219	28,955
Deferred income taxes	77,968	(38,924)
Working capital changes	(1,004,236)	456,405
Non-cash transfer of 40% value of construction in progress of Kemerton plant to MRL	115,969	135,928
Other, net	(37,047)	6,089
Net cash provided by operating activities	955,602	490,586
Cash flows from investing activities:
Capital expenditures	(815,934)	(652,739)
Proceeds from Divestiture of Businesses, Net of Cash Divested	0	289,791
Sales of marketable securities, net	3,132	4,407
Investments in equity and other corporate investments	(507)	(286)
Net cash used in investing activities	(813,309)	(358,827)
Cash flows from financing activities:
Proceeds from issuance of common stock	0	1,453,888
Repayments of long-term debt and credit agreements	(455,000)	(1,173,823)
Proceeds from borrowings of long-term debt and credit agreements	1,964,216	0
-391067000	(391,067)	(327,292)
Fees related to early extinguishment of debt	(9,767)	(24,877)
Dividends paid to shareholders	(138,165)	(132,236)
Dividends paid to noncontrolling interests	(44,208)	(61,178)
Proceeds from exercise of stock options	1,590	16,220
Withholding taxes paid on stock-based compensation award distributions	(12,150)	(7,755)
Other	(4,198)	(1,384)
Net cash provided by (used in) financing activities	911,251	(258,437)
Net effect of foreign exchange on cash and cash equivalents	(110,013)	(24,997)
Increase in cash and cash equivalents	943,531	(151,675)
Cash and cash equivalents at end of period	$ 1,382,803	$ 595,049

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation: In the opinion of management, the accompanying unaudited condensed consolidated financial statements of Albemarle Corporation and our wholly-owned, majority-owned and controlled subsidiaries (collectively, “Albemarle,” “we,” “us,” “our” or the “Company”) contain all adjustments necessary for a fair statement, in all material respects, of our consolidated balance sheets as of September 30, 2022 and December 31, 2021, our consolidated statements of income, consolidated statements of comprehensive income and consolidated statements of changes in equity for the three- and nine-month periods ended September 30, 2022 and 2021 and our condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2022 and 2021. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the U.S. Securities and Exchange Commission (“SEC”) on February 22, 2022. The December 31, 2021 consolidated balance sheet data herein was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles (“GAAP”) in the United States (“U.S.”). The results of operations for the three-and nine-month periods ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year. Certain reclassifications have been made to the accompanying condensed consolidated financial statements and the notes thereto to conform to the current presentation. Interest and financing expenses for the nine-month period ended September 30, 2022 include an expense of $17.5 million for the correction of out-of-period errors regarding overstated capitalized interest values in prior periods. For the years ended December 31, 2021, 2020 and 2019, Interest expense was understated by $11.4 million, $5.5 million and $0.6 million, respectively. The Company does not believe these adjustments are material to the consolidated financial statements for any of the prior periods presented or to the nine-month period ended September 30, 2022, in which they were corrected.

Business Combinations and Asset

Business Combinations and Asset Acquisitions	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	Acquisitions: On October 25, 2022 the Company completed the acquisition of all of the outstanding equity of Guangxi Tianyuan New Energy Materials Co., Ltd. (“Tianyuan”), for approximately $200 million in cash. Tianyuan's operations include a recently constructed lithium processing plant strategically positioned near the Port of Qinzhou in Guangxi, which began commercial production in the first half of 2022. The plant has designed annual conversion capacity of up to 25,000 metric tons of LCE and is capable of producing battery-grade lithium carbonate and lithium hydroxide. As this acquisition was completed on October 25, 2022, the preliminary fair value of the assets acquired and liabilities assumed are not recorded in the Company’s consolidated balance sheet as of September 30, 2022. The preliminary fair value of these assets and liabilities, as well as the results of operations of this acquisition, will be recorded in the fourth quarter of 2022. The Company has not completed the detailed valuation work necessary to arrive at the required estimates of the fair value of the assets acquired and liabilities assumed and the related allocation of purchase price.

Divestitures

Divestitures	9 Months Ended
	Sep. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure	Divestitures: On June 1, 2021, the Company completed the sale of its fine chemistry services (“FCS”) business to W. R. Grace & Co. (“Grace”) for proceeds of approximately $570 million, consisting of $300 million in cash and the issuance to Albemarle of preferred equity of a Grace subsidiary having an aggregate stated value of $270 million. The preferred equity can be redeemed at Grace’s option under certain conditions and will accrue payment-in-kind (“PIK”) dividends at an annual rate of 12% beginning two years after issuance. As part of the transaction, Grace acquired our manufacturing facilities located in South Haven, Michigan and Tyrone, Pennsylvania. The sale of the FCS business reflects the Company’s commitment to investing in its core, growth-oriented business segments. During the nine-month period ended September 30, 2021, we recorded a gain of $428.4 million ($330.9 million after income taxes) related to the sale of this business. Historical financial statements include results from this business until divested on June 1, 2021. We determined that the FCS business met the assets held for sale criteria in accordance with ASC 360, Property, Plant and Equipment during the first quarter of 2021. The results of operations of the business classified as held for sale are included in the consolidated statements of income through June 1, 2021. This business did not qualify for discontinued operations treatment because the Company’s management does not consider the sale as representing a strategic shift that had or will have a major effect on the Company’s operations and financial results.

Goodwill and Other Intangibles

Goodwill and Other Intangibles	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangibles	Goodwill and Other Intangibles: The following table summarizes the changes in goodwill by reportable segment for the nine months ended September 30, 2022 (in thousands): Lithium Bromine Catalysts Total Balance at December 31, 2021 $ 1,394,182 $ 20,319 $ 183,126 $ 1,597,627 Foreign currency translation adjustments (103,887) — (25,892) (129,779) Balance at September 30, 2022 $ 1,290,295 $ 20,319 $ 157,234 $ 1,467,848 The following table summarizes the changes in other intangibles and related accumulated amortization for the nine months ended September 30, 2022 (in thousands): Customer Lists and Relationships Trade Names and Trademarks (a) Patents and Technology Other Total Gross Asset Value Balance at December 31, 2021 $ 428,379 $ 17,883 $ 57,313 $ 36,705 $ 540,280 Additions — — — 3,813 3,813 Retirements — (4,253) (16,206) (5,844) (26,303) Foreign currency translation adjustments and other (45,283) (1,300) (4,902) (3,610) (55,095) Balance at September 30, 2022 $ 383,096 $ 12,330 $ 36,205 $ 31,064 $ 462,695 Accumulated Amortization Balance at December 31, 2021 $ (163,283) $ (7,983) $ (39,796) $ (20,271) $ (231,333) Amortization (15,756) — (1,017) (676) (17,449) Retirements — 4,253 16,206 5,844 26,303 Foreign currency translation adjustments and other 17,618 365 3,148 1,637 22,768 Balance at September 30, 2022 $ (161,421) $ (3,365) $ (21,459) $ (13,466) $ (199,711) Net Book Value at December 31, 2021 $ 265,096 $ 9,900 $ 17,517 $ 16,434 $ 308,947 Net Book Value at September 30, 2022 $ 221,675 $ 8,965 $ 14,746 $ 17,598 $ 262,984 (a) Net Book Value includes only indefinite-lived intangible assets.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes:The effective income tax rate for the three-month and nine-month periods ended September 30, 2022 was 22.7% and 23.3%, respectively, compared to 22.2% and 10.2% for the three-month and nine-month periods ended September 30, 2021, respectively. The three- and nine-month periods ended September 30, 2022 included a tax benefit related to global intangible low-taxed income, and net discrete tax benefits related to excess tax benefits realized from stock-based compensation arrangements and foreign return to provisions. The Company’s effective income tax rate fluctuates based on, among other factors, the amount and location of income. The three- and nine-month periods ended September 30, 2021 included a tax benefit of $152.9 million related to an accrual recorded as a subsequent event for the settlement of an arbitration ruling for a prior legal matter in October 2021. See Note 10, “Commitments and Contingencies,” for further details of this legal matter. The difference between the U.S. federal statutory income tax rate and our effective income tax rate for the three- and nine-month periods ended September 30, 2022 was impacted by a variety of factors, primarily global intangible low-taxed income and the location in which income was earned, and an uncertain tax position recorded in Chile. The difference between the U.S. federal statutory income tax rate and our effective income tax rate for the three-month and nine-month periods ended September 30, 2021 was impacted by a variety of factors, primarily global intangible low-taxed income, the location in which income was earned. In addition, the three- and nine-month periods ended September 30, 2021 includes a $97.5 million tax expense recorded for the gain on the sale of the FCS business, offset by the tax benefit for the settlement of the arbitration ruling noted above and a benefit from foreign rate differences.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share: Basic and diluted earnings per share for the three-month and nine-month periods ended September 30, 2022 and 2021 are calculated as follows (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Basic earnings per share Numerator: Net income (loss) attributable to Albemarle Corporation $ 897,215 $ (392,781) $ 1,557,371 $ 127,496 Denominator: Weighted-average common shares for basic earnings per share 117,136 116,965 117,106 115,455 Basic earnings (loss) per share $ 7.66 $ (3.36) $ 13.30 $ 1.10 Diluted earnings per share Numerator: Net income (loss) attributable to Albemarle Corporation $ 897,215 $ (392,781) $ 1,557,371 $ 127,496 Denominator: Weighted-average common shares for basic earnings per share 117,136 116,965 117,106 115,455 Incremental shares under stock compensation plans 733 — 643 685 Weighted-average common shares for diluted earnings per share 117,869 116,965 117,749 116,140 Diluted earnings (loss) per share $ 7.61 $ (3.36) $ 13.23 $ 1.10 On February 8, 2021, we completed an underwritten public offering of 8,496,773 shares of our common stock, par value $0.01 per share, at a price to the public of $153.00 per share. The Company also granted to the underwriters an option to purchase up to an additional 1,274,509 shares, which was exercised. The total gross proceeds from this offering were approximately $1.5 billion, before deducting expenses, underwriting discounts and commissions. The net proceeds were used for debt repayments and general corporate purposes. On July 18, 2022, the Company declared a cash dividend of $0.395, an increase from the prior year regular quarterly dividend. This dividend was paid on October 3, 2022 to shareholders of record at the close of business as of September 16, 2022. On October 24, 2022, the Company declared a cash dividend of $0.395 per share, which is payable on January 3, 2023 to shareholders of record at the close of business as of December 16, 2022.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories: The following table provides a breakdown of inventories at September 30, 2022 and December 31, 2021 (in thousands): September 30, December 31, 2022 2021 Finished goods $ 1,244,674 $ 459,536 Raw materials and work in process (a) 277,594 259,221 Stores, supplies and other 92,031 79,863 Total $ 1,614,299 $ 798,620 (a) Included $132.1 million and $149.4 million at September 30, 2022 and December 31, 2021, respectively, of work in process in our Lithium segment.

Investments

Investments	9 Months Ended
	Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]
Investments	Investments:The Company holds a 49% equity interest in Windfield Holdings Pty. Ltd. (“Talison”), where the ownership parties share risks and benefits disproportionate to their voting interests. As a result, the Company considers Talison to be a variable interest entity (“VIE”), however this investment is not consolidated as the Company is not the primary beneficiary. The carrying amount of our 49% equity interest in Windfield, which is our most significant VIE, was $706.5 million and $476.6 million at September 30, 2022 and December 31, 2021, respectively. The Company’s aggregate net investment in all other entities which it considers to be VIEs of which the Company is not the primary beneficiary was $7.2 million at September 30, 2022 and $8.0 million at December 31, 2021. The Company’s unconsolidated VIEs are reported in Investments on the consolidated balance sheets. The Company does not guarantee debt for, or have other financial support obligations to, these entities, and its maximum exposure to loss in connection with its continuing involvement with these entities is limited to the carrying value of the investments. Effective September 30, 2022 the Company began recording the balance of deferred profits on sales from its equity method investments to the Company to Inventories, specifically finished goods. Historically this balance was recorded in Investments in the consolidated balance sheets. As a result, the historical balances have been reclassified to reflect the current period presentation. This change in presentation was made to better align the location of these deferred profits with their respective inventory balances until they are sold to a third party. Deferred profits from equity method investments totaled $222.1 million and $14.3 million as of September 30, 2022 and December 31, 2021, respectively, with the increase primarily driven by increased pricing and volume of sales from the Talison joint venture. There was no impact to the statements of income, comprehensive (loss) income, changes in equity or cash flows for any period as a result of this change in presentation. In addition, the Company does not believe this change in presentation is material to the consolidated financial statements for any prior period. As part of the proceeds from the sale of the FCS business on June 1, 2021, Grace issued Albemarle preferred equity of a Grace subsidiary having an aggregate stated value of $270 million. The preferred equity can be redeemed at Grace’s option under certain conditions and will accrue PIK dividends at an annual rate of 12% beginning two years after issuance. This preferred equity had a fair value of $253.7 million and $246.5 million at September 30, 2022 and December 31, 2021, respectively, which is reported in Investments in the consolidated balance sheets.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Long-term Debt	Long-Term Debt: Long-term debt at September 30, 2022 and December 31, 2021 consisted of the following (in thousands): September 30, December 31, 2022 2021 1.125% notes due 2025 $ 361,818 $ 426,571 1.625% notes due 2028 479,700 565,550 3.45% Senior notes due 2029 171,612 171,612 4.15% Senior notes due 2024 — 425,000 4.65% Senior notes due 2027 650,000 — 5.05% Senior notes due 2032 600,000 — 5.45% Senior notes due 2044 350,000 350,000 5.65% Senior notes due 2052 450,000 — Credit facilities 250,000 — Commercial paper notes — 388,500 Variable-rate foreign bank loans 2,763 5,226 Finance lease obligations 71,975 75,431 Other 11,252 — Unamortized discount and debt issuance costs (29,151) (13,651) Total long-term debt 3,369,969 2,394,239 Less amounts due within one year 251,216 389,920 Long-term debt, less current portion $ 3,118,753 $ 2,004,319 On May 13, 2022, the Company issued a series of notes (collectively, the “2022 Notes”) as follows: • $650.0 million aggregate principal amount of senior notes, bearing interest at a rate of 4.65% payable semi-annually on June 1 and December 1 of each year, beginning on December 1, 2022. The effective interest rate on these senior notes is approximately 4.84%. These senior notes mature on June 1, 2027. • $600.0 million aggregate principal amount of senior notes, bearing interest at a rate of 5.05% payable semi-annually on June 1 and December 1 of each year, beginning on December 1, 2022. The effective interest rate on these senior notes is approximately 5.18%. These senior notes mature on June 1, 2032. • $450.0 million aggregate principal amount of senior notes, bearing interest at a rate of 5.65% payable semi-annually on June 1 and December 1 of each year, beginning on December 1, 2022. The effective interest rate on these senior notes is approximately 5.71%. These senior notes mature on June 1, 2052. The net proceeds from the issuance of the 2022 Notes were used to repay the balance of the commercial paper notes, the remaining balance of $425.0 million of the 4.15% Senior Notes due 2024 (the “2024 Notes”) and for general corporate purposes. The 2024 Notes were originally due to mature on December 15, 2024 and bore interest at a rate of 4.15%. During the nine-month period ended September 30, 2022, the Company recorded a loss on early extinguishment of debt of $19.2 million in Interest and financing expenses, representing the tender premiums, fees, unamortized discounts and unamortized deferred financing costs from the redemption of the 2024 Notes. In addition, the loss on early extinguishment of debt includes the accelerated amortization of the interest rate swap associated with the 2024 Notes from Accumulated other comprehensive income. On October 28, 2022, we amended our revolving, unsecured credit agreement (the “2018 Credit Agreement”), which provides for borrowings of up to $1.5 billion and matures on October 28, 2027. This credit agreement was originally dated as of June 21, 2018, and was previously amended on August 14, 2019, May 11, 2020 and December 10, 2021. Borrowings under the 2018 Credit Agreement bear interest at variable rates based on a benchmark rate depending on the currency in which the loans are denominated, plus an applicable margin which ranges from 0.91% to 1.375%, depending on the Company’s credit rating from Standard & Poor’s Ratings Services LLC, Moody’s Investors Services, Inc. and Fitch Ratings, Inc. With respect to loans denominated in U.S. dollars, interest is calculated using the term Secured Overnight Financing Rate (“SOFR”) plus a term SOFR adjustment of 0.10%, plus the applicable margin. During the second quarter of 2022 the Company drew $250 million under the unsecured credit facility originally entered into on August 14, 2019, as amended and restated on December 15, 2020 and again on December 10, 2021 (the “2019 Credit Facility”) for general corporate purposes. The applicable margin on the 2019 Credit Facility was 1.125% at September 30, 2022. On October 24, 2022, the 2019 Credit Facility was terminated, with the outstanding balance of $250 million repaid using cash on hand. In the first quarter of 2021, the Company made certain debt principal payments using proceeds from the February 2021 underwritten public offering of common stock. As a result, included in Interest and financing expenses for the nine-month period ended September 30, 2021 is a loss on early extinguishment of debt of $29.0 million representing the tender premiums, fees, unamortized discounts and unamortized deferred financing costs from the redemption of this debt.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies: Environmental The following activity was recorded in environmental liabilities for the nine months ended September 30, 2022 (in thousands): Beginning balance at December 31, 2021 $ 46,617 Expenditures (2,495) Accretion of discount 777 Additions and changes in estimates 2,811 Foreign currency translation adjustments and other (3,533) Ending balance at September 30, 2022 44,177 Less amounts reported in Accrued expenses 9,496 Amounts reported in Other noncurrent liabilities $ 34,681 Environmental remediation liabilities included discounted liabilities of $37.3 million and $39.7 million at September 30, 2022 and December 31, 2021, respectively, discounted at rates with a weighted-average of 3.5%, and with the undiscounted amount totaling $65.2 million and $70.0 million at September 30, 2022 and December 31, 2021, respectively. For certain locations where the Company is operating groundwater monitoring and/or remediation systems, prior owners or insurers have assumed all or most of the responsibility. The amounts recorded represent our future remediation and other anticipated environmental liabilities. These liabilities typically arise during the normal course of our operational and environmental management activities or at the time of acquisition of the site, and are based on internal analysis as well as input from outside consultants. As evaluations proceed at each relevant site, changes in risk assessment practices, remediation techniques and regulatory requirements can occur, therefore such liability estimates may be adjusted accordingly. The timing and duration of remediation activities at these sites will be determined when evaluations are completed. Although it is difficult to quantify the potential financial impact of these remediation liabilities, management estimates (based on the latest available information) that there is a reasonable possibility that future environmental remediation costs associated with our past operations could represent an additional $9 million before income taxes, in excess of amounts already recorded. We believe that any sum we may be required to pay in connection with environmental remediation matters in excess of the amounts recorded would likely occur over a period of time and would likely not have a material adverse effect upon our results of operations, financial condition or cash flows on a consolidated annual basis although any such sum could have a material adverse impact on our results of operations, financial condition or cash flows in a particular quarterly reporting period. Litigation We are involved from time to time in legal proceedings of types regarded as common in our business, including administrative or judicial proceedings seeking remediation under environmental laws, such as the federal Comprehensive Environmental Response, Compensation and Liability Act, commonly known as CERCLA or Superfund, products liability, breach of contract liability and premises liability litigation. Where appropriate, we may establish financial reserves for such proceedings. We also maintain insurance to mitigate certain of such risks. Costs for legal services are generally expensed as incurred. On February 6, 2017, Huntsman International LLC (“Huntsman”), a subsidiary of Huntsman Corporation, filed a lawsuit in New York state court against Rockwood Holdings, Inc. (“Rockwood”), Rockwood Specialties, Inc., certain former executives of Rockwood and its subsidiaries, Seifollah Ghasemi, Thomas Riordan, Andrew Ross, and Michael Valente, and Albemarle. The lawsuit arises out of Huntsman’s acquisition of certain Rockwood subsidiaries in connection with a stock purchase agreement (the “SPA”), dated September 17, 2013. Before that transaction closed on October 1, 2014, Albemarle began discussions with Rockwood to purchase all outstanding equity of Rockwood and did so in a transaction that closed on January 12, 2015. Huntsman’s complaint asserted that certain technology that Rockwood had developed for a production facility in Augusta, Georgia, and which was among the assets that Huntsman acquired pursuant to the SPA, did not work, and that Rockwood and the defendant executives had intentionally misled Huntsman about that technology in connection with the Huntsman-Rockwood transaction. The complaint asserted claims for, among other things, fraud, negligent misrepresentation, and breach of the SPA, and sought certain costs for completing construction of the production facility. On March 10, 2017, Albemarle moved in New York state court to compel arbitration, which was granted on January 8, 2018 (although Huntsman unsuccessfully appealed that decision). Huntsman’s arbitration demand asserted claims substantially similar to those asserted in its state court complaint, and sought various forms of legal remedies, including cost overruns, compensatory damages, expectation damages, punitive damages, and restitution. After a trial, the arbitration panel issued an award on October 28, 2021, awarding approximately $600 million (including interest) to be paid by Albemarle to Huntsman, in addition to the possibility of attorney’s fees, costs and expenses. Following the arbitration panel decision, Albemarle reached a settlement with Huntsman to pay $665 million in two equal installments, with the first payment made in December 2021. The second and final payment of $332.5 million was made in May 2022. As a result, the consolidated statements of income for the three- and nine-month periods ended September 30, 2021, included a loss of $657.4 million ($504.5 million net of income tax), inclusive of estimated possible legal fees incurred by Huntsman and other related obligations, to reflect the increase in liabilities for this legal matter. As first reported in 2018, following receipt of information regarding potential improper payments being made by third-party sales representatives of our Refining Solutions business, within our Catalysts segment, we promptly retained outside counsel and forensic accountants to investigate potential violations of the Company’s Code of Conduct, the Foreign Corrupt Practices Act, and other potentially applicable laws. Based on this internal investigation, we have voluntarily self-reported potential issues relating to the use of third-party sales representatives in our Refining Solutions business, within our Catalysts segment, to the U.S. Department of Justice (“DOJ”), the SEC, and the Dutch Public Prosecutor (“DPP”), and are cooperating with the DOJ, the SEC, and the DPP in their review of these matters. In connection with our internal investigation, we have implemented, and are continuing to implement, appropriate remedial measures. We have commenced discussions with the SEC, DOJ and DPP about a potential resolution of these matters. At this time, we are unable to predict the duration, scope, result, or related costs associated with the investigations. We also are unable to predict what action may be taken by the DOJ, the SEC, or the DPP, or what penalties or remedial actions they may ultimately seek. Any determination that our operations or activities are not, or were not, in compliance with existing laws or regulations could result in the imposition of fines, penalties, disgorgement, equitable relief, or other losses. We do not believe, however, that any such fines, penalties, disgorgement, equitable relief, or other losses would have a material adverse effect on our financial condition or liquidity. However, an adverse resolution could have a material adverse effect on our results of operations in a particular period. Indemnities We are indemnified by third parties in connection with certain matters related to acquired and divested businesses. Although we believe that the financial condition of those parties who may have indemnification obligations to the Company is generally sound, in the event the Company seeks indemnity under any of these agreements or through other means, there can be no assurance that any party who may have obligations to indemnify us will adhere to their obligations and we may have to resort to legal action to enforce our rights under the indemnities. The Company may be subject to indemnity claims relating to properties or businesses it divested, including properties or businesses of acquired businesses that were divested prior to the completion of the acquisition. In the opinion of management, and based upon information currently available, the ultimate resolution of any indemnification obligations owed to the Company or by the Company is not expected to have a material effect on the Company’s financial condition, results of operations or cash flows. The Company had approximately $55.8 million and $66.8 million at September 30, 2022 and December 31, 2021, respectively, recorded in Other noncurrent liabilities, primarily related to the indemnification of certain income and non-income tax liabilities associated with the Chemetall Surface Treatment entities sold in 2017. Other We have contracts with certain of our customers which serve as guarantees on product delivery and performance according to customer specifications that can cover both shipments on an individual basis, as well as blanket coverage of multiple shipments under certain customer supply contracts. The financial coverage provided by these guarantees is typically based on a percentage of net sales value.

Leases

Leases	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Leases	Leases: We lease certain office space, buildings, transportation and equipment in various countries. The initial lease terms generally range from 1 to 30 years for real estate leases, and from 2 to 15 years for non-real estate leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and we recognize lease expense for these leases on a straight-line basis over the lease term. Many leases include options to terminate or renew, with renewal terms that can extend the lease term from 1 to 50 years or more. The exercise of lease renewal options is at our sole discretion. Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. The following table provides details of our lease contracts for the three-month and nine-month periods ended September 30, 2022 and 2021 (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Operating lease cost $ 11,456 $ 13,807 $ 32,657 $ 32,954 Finance lease cost: Amortization of right of use assets 952 153 2,354 466 Interest on lease liabilities 826 722 2,519 2,229 Total finance lease cost 1,778 875 4,873 2,695 Short-term lease cost 4,171 2,949 10,141 7,729 Variable lease cost 3,179 2,441 5,810 6,619 Total lease cost $ 20,584 $ 20,072 $ 53,481 $ 49,997 Supplemental cash flow information related to our lease contracts for the nine-month periods ended September 30, 2022 and 2021 is as follows (in thousands): Nine Months Ended September 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 27,201 $ 24,462 Operating cash flows from finance leases 2,360 1,295 Financing cash flows from finance leases 999 471 Right-of-use assets obtained in exchange for lease obligations: Operating leases 8,378 57,136 Supplemental balance sheet information related to our lease contracts, including the location on balance sheet, at September 30, 2022 and December 31, 2021 is as follows (in thousands, except as noted): September 30, 2022 December 31, 2021 Operating leases: Other assets $ 130,257 $ 154,741 Accrued expenses 30,039 31,603 Other noncurrent liabilities 102,198 126,997 Total operating lease liabilities 132,237 158,600 Finance leases: Net property, plant and equipment 70,968 75,302 Current portion of long-term debt (a) 3,723 3,768 Long-term debt 70,758 74,011 Total finance lease liabilities 74,481 77,779 Weighted average remaining lease term (in years): Operating leases 13.7 12.9 Finance leases 24.5 24.5 Weighted average discount rate (%): Operating leases 3.60 % 3.44 % Finance leases 4.41 % 4.47 % (a) Balance includes accrued interest of finance lease recorded in Accrued liabilities. Maturities of lease liabilities at September 30, 2022 were as follows (in thousands): Operating Leases Finance Leases Remainder of 2022 $ 9,376 $ 1,470 2023 33,845 5,879 2024 21,552 5,879 2025 12,328 5,879 2026 9,977 5,303 Thereafter 121,460 96,580 Total lease payments 208,538 120,990 Less imputed interest 76,301 46,509 Total $ 132,237 $ 74,481
Leases	Leases: We lease certain office space, buildings, transportation and equipment in various countries. The initial lease terms generally range from 1 to 30 years for real estate leases, and from 2 to 15 years for non-real estate leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and we recognize lease expense for these leases on a straight-line basis over the lease term. Many leases include options to terminate or renew, with renewal terms that can extend the lease term from 1 to 50 years or more. The exercise of lease renewal options is at our sole discretion. Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. The following table provides details of our lease contracts for the three-month and nine-month periods ended September 30, 2022 and 2021 (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Operating lease cost $ 11,456 $ 13,807 $ 32,657 $ 32,954 Finance lease cost: Amortization of right of use assets 952 153 2,354 466 Interest on lease liabilities 826 722 2,519 2,229 Total finance lease cost 1,778 875 4,873 2,695 Short-term lease cost 4,171 2,949 10,141 7,729 Variable lease cost 3,179 2,441 5,810 6,619 Total lease cost $ 20,584 $ 20,072 $ 53,481 $ 49,997 Supplemental cash flow information related to our lease contracts for the nine-month periods ended September 30, 2022 and 2021 is as follows (in thousands): Nine Months Ended September 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 27,201 $ 24,462 Operating cash flows from finance leases 2,360 1,295 Financing cash flows from finance leases 999 471 Right-of-use assets obtained in exchange for lease obligations: Operating leases 8,378 57,136 Supplemental balance sheet information related to our lease contracts, including the location on balance sheet, at September 30, 2022 and December 31, 2021 is as follows (in thousands, except as noted): September 30, 2022 December 31, 2021 Operating leases: Other assets $ 130,257 $ 154,741 Accrued expenses 30,039 31,603 Other noncurrent liabilities 102,198 126,997 Total operating lease liabilities 132,237 158,600 Finance leases: Net property, plant and equipment 70,968 75,302 Current portion of long-term debt (a) 3,723 3,768 Long-term debt 70,758 74,011 Total finance lease liabilities 74,481 77,779 Weighted average remaining lease term (in years): Operating leases 13.7 12.9 Finance leases 24.5 24.5 Weighted average discount rate (%): Operating leases 3.60 % 3.44 % Finance leases 4.41 % 4.47 % (a) Balance includes accrued interest of finance lease recorded in Accrued liabilities. Maturities of lease liabilities at September 30, 2022 were as follows (in thousands): Operating Leases Finance Leases Remainder of 2022 $ 9,376 $ 1,470 2023 33,845 5,879 2024 21,552 5,879 2025 12,328 5,879 2026 9,977 5,303 Thereafter 121,460 96,580 Total lease payments 208,538 120,990 Less imputed interest 76,301 46,509 Total $ 132,237 $ 74,481

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Segment Information	Segment Information:During 2022, the Company’s three reportable segments include: (1) Lithium; (2) Bromine; and (3) Catalysts. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. This business structure aligns with the markets and customers we serve through each of the segments. This structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions. In August 2022, the Company announced plans to realign its Lithium and Bromine global business units into a new corporate structure designed to better meet customer needs and foster talent required to deliver in a competitive global environment. In addition, the Company announced its decision to retain its Catalysts business under a separate, wholly-owned subsidiary. The realignment is expected to be completed in the first quarter of 2023, and will result in the following three reportable segments: (1) Energy Storage; (2) Specialties; and (3) Catalysts. The Company will continue to report its segments in its current structure until the new structure becomes effective. Summarized financial information concerning our reportable segments is shown in the following tables. The “All Other” category included only the FCS business that did not fit into any of our core businesses. On June 1, 2021, we completed the sale of the FCS business. See Note 3, “Divestitures,” for additional information. Amounts in the “All Other” category represent activity in this business until divested on June 1, 2021. The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the operating segments. Pension and other post-employment benefit (“OPEB”) service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes inter-segment transfers of raw materials at cost and allocations for certain corporate costs. The Company’s chief operating decision maker uses adjusted EBITDA (as defined below) to assess the ongoing performance of the Company’s business segments and to allocate resources. The Company defines adjusted EBITDA as earnings before interest and financing expenses, income tax expenses, depreciation and amortization, as adjusted on a consistent basis for certain non-operating, non-recurring or unusual items in a balanced manner and on a segment basis. These non-operating, non-recurring or unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, certain litigation and arbitration costs and charges, non-operating pension and OPEB items and other significant non-recurring items. In addition, management uses adjusted EBITDA for business and enterprise planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to Net (loss) income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP. Three Months Ended Nine Months Ended 2022 2021 2022 2021 (In thousands) (In thousands) Net sales: Lithium $ 1,501,073 $ 359,229 $ 2,942,861 $ 958,539 Bromine 354,908 277,783 1,092,239 837,978 Catalysts 235,824 193,554 664,026 562,141 All Other — — — 75,095 Total net sales $ 2,091,805 $ 830,566 $ 4,699,126 $ 2,433,753 Adjusted EBITDA: Lithium $ 1,111,243 $ 125,416 $ 1,915,066 $ 341,293 Bromine 106,958 86,012 371,875 273,298 Catalysts 4,635 33,103 31,337 79,694 All Other — — — 29,858 Corporate (32,870) (26,962) (86,173) (81,892) Total adjusted EBITDA $ 1,189,966 $ 217,569 $ 2,232,105 $ 642,251 See below for a reconciliation of adjusted EBITDA, a non-GAAP financial measure, from Net (loss) income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands): Lithium Bromine Catalysts All Other Corporate Consolidated Total Three months ended September 30, 2022 Net income (loss) attributable to Albemarle Corporation $ 1,063,426 $ 93,186 $ (12,473) $ — $ (246,924) $ 897,215 Depreciation and amortization 47,758 13,772 12,689 — 3,494 77,713 Acquisition and integration related costs (a) — — — — 2,145 2,145 Interest and financing expenses — — — — 29,691 29,691 Income tax expense — — — — 196,938 196,938 Non-operating pension and OPEB items — — — — (5,027) (5,027) Other (b) 59 — 4,419 — (13,187) (8,709) Adjusted EBITDA $ 1,111,243 $ 106,958 $ 4,635 $ — $ (32,870) $ 1,189,966 Three months ended September 30, 2021 Net income (loss) attributable to Albemarle Corporation $ 92,449 $ 73,409 $ 20,039 $ — $ (578,678) $ (392,781) Depreciation and amortization 34,256 12,603 13,064 — 2,159 62,082 Restructuring and other (c) — — — — 754 754 Gain on sale of business (d) — — — — 984 984 Acquisition and integration related costs (a) — — — — 1,553 1,553 Interest and financing expenses — — — — 5,136 5,136 Income tax expense — — — — (114,670) (114,670) Non-operating pension and OPEB items — — — — (5,471) (5,471) Legal accrual (e) — — — — 657,412 657,412 Other (f) (1,289) — — — 3,859 2,570 Adjusted EBITDA $ 125,416 $ 86,012 $ 33,103 $ — $ (26,962) $ 217,569 Nine months ended September 30, 2022 Net income (loss) attributable to Albemarle Corporation $ 1,777,214 $ 332,208 $ (11,867) $ — $ (540,184) $ 1,557,371 Depreciation and amortization 128,786 39,667 38,785 — 8,042 215,280 Loss on sale of interest in properties (g) 8,400 — — — — 8,400 Acquisition and integration related costs (a) — — — — 9,244 9,244 Interest and financing expenses (h) — — — — 98,934 98,934 Income tax expense — — — — 366,486 366,486 Non-operating pension and OPEB items — — — — (15,345) (15,345) Other (b) 666 — 4,419 — (13,350) (8,265) Adjusted EBITDA $ 1,915,066 $ 371,875 $ 31,337 $ — $ (86,173) $ 2,232,105 Nine months ended September 30, 2021 Net income (loss) attributable to Albemarle Corporation $ 237,293 $ 235,670 $ 41,401 $ 27,988 $ (414,856) $ 127,496 Depreciation and amortization 99,559 37,628 38,293 1,870 8,415 185,765 Restructuring and other (c) — — — — 2,294 2,294 Gain on sale of business (d) — — — — (428,424) (428,424) Acquisition and integration related costs (a) — — — — 5,629 5,629 Interest and financing expenses (h) — — — — 56,170 56,170 Income tax expense — — — — 14,422 14,422 Non-operating pension and OPEB items — — — — (16,407) (16,407) Legal accrual (e) — — — — 657,412 657,412 Albemarle Foundation contribution (i) — — — — 20,000 20,000 Other (f) 4,441 — — — 13,453 17,894 Adjusted EBITDA $ 341,293 $ 273,298 $ 79,694 $ 29,858 $ (81,892) $ 642,251 (a) Costs related to the acquisition, integration and potential divestitures for various significant projects, recorded in Selling, general and administrative expenses (“SG&A”). (b) Included amounts for the three months ended September 30, 2022 recorded in: • Cost of goods sold - $2.7 million of expense related to one-time retention payments for certain employees during the Catalysts strategic review and business unit realignment. • SG&A - $1.9 million of expense primarily related to one-time retention payments for certain employees during the Catalysts strategic review and business unit realignment and $1.3 million primarily related to facility closure expenses of offices in Germany. • Other income, net - $10.6 million net gain related to the fair value adjustment of equity securities in a public company, a $3.0 million gain from the reversal of a liability related to a previous divestiture and $1.1 million of gain resulting from the adjustment of indemnification related to previously disposed businesses. Included amounts for the nine months ended September 30, 2022 recorded in: • Cost of goods sold - $2.7 million of expense related to one-time retention payments for certain employees during the Catalysts strategic review and business unit realignment, and $0.5 million related to the settlement of a legal matter resulting from a prior acquisition. • SG&A - $3.2 million primarily related to facility closure expenses of offices in Germany, $2.8 million of charges for environmental reserves at sites not part of our operations and $1.9 million of expense primarily related to one-time retention payments for certain employees during the Catalysts strategic review, partially offset by $4.3 million of gains from the sale of legacy properties not part of our operations. • Other income, net - $10.6 million net gain related to the fair value adjustment of equity securities in a public company, a $3.0 million gain from the reversal of a liability related to a previous divestiture, $1.1 million of gain resulting from the adjustment of indemnification related to previously disposed businesses and a $0.6 million gain related to a settlement received from a legal matter in a prior period. (c) In 2021, the Company recorded facility closure related to offices in Germany, and severance expenses in Germany and Belgium, in SG&A. (d) See Note 3, “Divestitures,” for additional information. (e) Loss recorded in Other expense, net in the three and nine months ended September 30, 2021 related to the settlement of an arbitration ruling for a prior legal matter. See Note 10, “Commitments and Contingencies,” for further details. (f) Included amounts for the three months ended September 30, 2021 recorded in: • SG&A - $2.5 million of expenses primarily related to non-routine labor and compensation related costs that are outside normal compensation arrangements. • Other income, net - $0.1 million of loss resulting from the adjustment of indemnification related to previously disposed businesses. Included amounts for the nine months ended September 30, 2021 recorded in: • SG&A - $8.6 million of expenses primarily related to non-routine labor and compensation related costs that are outside normal compensation arrangements, a $4.0 million loss resulting from the sale of property, plant and equipment and $1.6 million of charges for an environmental reserve at a site not part of our operations. • Other income, net - $3.7 million of expenses primarily related to asset retirement obligation charges to update of an estimate at a site formerly owned by Albemarle. (g) Expense recorded as a result of revised estimates of the obligation to construct certain lithium hydroxide conversion assets in Kemerton, Western Australia, due to cost overruns from supply chain, labor and COVID-19 pandemic related issues. The corresponding obligation was recorded in Accrued liabilities to be transferred to Mineral Resources Limited (“MRL”), which maintains a 40% ownership interest in these Kemerton assets. (h) Included in Interest and financing expenses is a loss on early extinguishment of debt of $19.2 million and $29.0 million for the nine months ended September 30, 2022 and 2021, respectively. See Note 9, “Long-term Debt,” for additional information. In addition, Interest and financing expenses for the nine months ended September 30, 2022 includes the correction of an out of period error of $17.5 million related to the overstatement of capitalized interest in prior periods. See Note 1, “Basis of Presentation,” for further details. (i) Included in SG&A is a charitable contribution, using a portion of the proceeds received from the FCS divestiture, to the Albemarle Foundation, a non-profit organization that sponsors grants, health and social projects, educational initiatives, disaster relief, matching gift programs, scholarships and other charitable initiatives in locations where the Company’s employees live and the Company operates. This contribution is in addition to the normal annual contribution made to the Albemarle Foundation by the Company, and is significant in size and nature in that it is intended to provide more long-term benefits in these communities.

Pension Plans and Other Postret

Pension Plans and Other Postretirement Benefits	9 Months Ended
	Sep. 30, 2022
Retirement Benefits [Abstract]
Pension Plans and Other Postretirement Benefits	Pension Plans and Other Postretirement Benefits: The components of pension and postretirement benefits cost (credit) for the three-month and nine-month periods ended September 30, 2022 and 2021 were as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Pension Benefits Cost (Credit): Service cost $ 959 $ 1,425 $ 2,914 $ 3,776 Interest cost 5,530 5,113 16,703 15,352 Expected return on assets (10,884) (10,893) (33,028) (32,687) Amortization of prior service benefit 21 29 68 87 Total net pension benefits credit $ (4,374) $ (4,326) $ (13,343) $ (13,472) Postretirement Benefits Cost: Service cost $ 21 $ 31 $ 64 $ 93 Interest cost 327 309 980 928 Total net postretirement benefits cost $ 348 $ 340 $ 1,044 $ 1,021 Total net pension and postretirement benefits credit $ (4,026) $ (3,986) $ (12,299) $ (12,451) All components of net benefit cost (credit), other than service cost, are included in Other income, net on the consolidated statements of income. During the three-month and nine-month periods ended September 30, 2022, the Company made contributions of $2.5 million and $8.9 million, respectively, to its qualified and nonqualified pension plans. During the three-month and nine-month periods ended September 30, 2021, the Company made contributions of $3.2 million and $22.1 million, respectively, to its qualified and nonqualified pension plans. The contributions made in 2021 included deferred contributions from the prior year resulting from uncertainty during the COVID-19 pandemic.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments: In assessing the fair value of financial instruments, we use methods and assumptions that are based on market conditions and other risk factors existing at the time of assessment. Fair value information for our financial instruments is as follows: Long-Term Debt—the fair values of our notes are estimated using Level 1 inputs and account for the difference between the recorded amount and fair value of our long-term debt. The carrying value of our remaining long-term debt reported in the accompanying consolidated balance sheets approximates fair value as substantially all of such debt bears interest based on prevailing variable market rates currently available in the countries in which we have borrowings. September 30, 2022 December 31, 2021 Recorded Fair Value Recorded Fair Value (In thousands) Long-term debt $ 3,393,136 $ 3,091,805 $ 2,405,021 $ 2,593,590 Foreign Currency Forward Contracts—during the fourth quarter of 2019, we entered into a foreign currency forward contract to hedge the cash flow exposure of non-functional currency purchases during the construction of the Kemerton plant in Australia. This derivative financial instrument is used to manage risk and is not used for trading or other speculative purposes. This foreign currency forward contract has been designated as a hedging instrument under ASC 815, Derivatives and Hedging . We had outstanding designated foreign currency forward contracts with notional values totaling the equivalent of $101.6 million and $36.5 million at September 30, 2022 and December 31, 2021, respectively. We also enter into foreign currency forward contracts in connection with our risk management strategies that have not been designated as hedging instruments under ASC 815, Derivatives and Hedging , in an attempt to minimize the financial impact of changes in foreign currency exchange rates. These derivative financial instruments are used to manage risk and are not used for trading or other speculative purposes. The fair values of our non-designated foreign currency forward contracts are estimated based on current settlement values. At September 30, 2022 and December 31, 2021, we had outstanding non-designated foreign currency forward contracts with notional values totaling $2,057.7 million and $618.1 million, respectively, hedging our exposure to various currencies including the Chilean Peso, Euro, Chinese Renminbi, Japanese Yen, Australian Dollar and Singapore Dollar. The following table summarizes the fair value of our foreign currency forward contracts included in the consolidated balance sheets as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 December 31, 2021 Assets Liabilities Assets Liabilities Designated as hedging instruments Other current assets $ — $ — $ 237 $ — Accrued expenses — 9,169 — 57 Total designated as hedging instruments — 9,169 237 57 Not designated as hedging instruments Other current assets 4,968 — 2,901 — Accrued expenses — 50 — 248 Total not designated as hedging instruments 4,968 50 2,901 248 Total $ 4,968 $ 9,219 $ 3,138 $ 305 The following table summarizes the net gains (losses) recognized for our foreign currency forward contracts during the three-month and nine-month periods ended September 30, 2022 and 2021 (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Designated as hedging instruments (Loss) income recognized in Other comprehensive loss $ (9,653) $ 214 $ (8,144) $ (563) Not designated as hedging instruments (Loss) income recognized in Other income, net (a) $ (9,056) $ (1,199) $ (36,326) $ 658 (a) Fluctuations in the value of our foreign currency forward contracts not designated as hedging instruments are generally expected to be offset by changes in the value of the underlying exposures being hedged, which are also reported in Other income, net. In addition, for the nine-month periods ended September 30, 2022 and 2021, we recorded net cash (settlements) receipts of ($38.6) million and $0.8 million, respectively, in Other, net, in our condensed consolidated statements of cash flows. Unrealized gains and losses related to the cash flow hedges will be reclassified to earnings over the life of the related assets when settled and the related assets are placed into service. The counterparties to our foreign currency forward contracts are major financial institutions with which we generally have other financial relationships. We are exposed to credit loss in the event of nonperformance by these counterparties. However, we do not anticipate nonperformance by the counterparties.

Fair Value Measurement

Fair Value Measurement	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurement	Fair Value Measurement:Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The inputs used to measure fair value are classified into the following hierarchy: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities Level 2 Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability Level 3 Unobservable inputs for the asset or liability We endeavor to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following tables set forth our financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 Quoted Prices in Active Markets for Identical Items (Level 1) Quoted Prices in Active Markets for Similar Items (Level 2) Unobservable Inputs (Level 3) Assets: Available for sale debt securities (a) $ 253,701 $ — $ — $ 253,701 Investments under executive deferred compensation plan (b) $ 25,495 $ 25,495 $ — $ — Public equity securities (c) $ 12,197 $ 12,197 $ — $ — Private equity securities measured at net asset value (d)(e) $ 4,716 $ — $ — $ — Foreign currency forward contracts (f) $ 4,968 $ — $ 4,968 $ — Liabilities: Obligations under executive deferred compensation plan (b) $ 25,495 $ 25,495 $ — $ — Foreign currency forward contracts (f) $ 9,219 $ — $ 9,219 $ — December 31, 2021 Quoted Prices in Active Markets for Identical Items (Level 1) Quoted Prices in Active Markets for Similar Items (Level 2) Unobservable Inputs (Level 3) Assets: Available for sale debt securities (a) $ 246,517 $ — $ — $ 246,517 Investments under executive deferred compensation plan (b) $ 32,491 $ 32,491 $ — $ — Private equity securities measured at net asset value (d)(e) $ 4,696 $ — $ — $ — Foreign currency forward contracts (f) $ 3,138 $ — $ 3,138 $ — Liabilities: Obligations under executive deferred compensation plan (b) $ 32,491 $ 32,491 $ — $ — Foreign currency forward contracts (f) $ 305 $ — $ 305 $ — (a) Preferred equity of a Grace subsidiary acquired as a portion of the proceeds of the FCS sale on June 1, 2021. See Note 2, “Divestitures,” for further details on the material terms and conditions. A third-party estimate of the fair value was prepared using expected future cash flows over the period up to when the asset is likely to be redeemed, applying a discount rate that appropriately captures a market participant's view of the risk associated with the investment. These are considered to be Level 3 inputs. (b) We maintain an Executive Deferred Compensation Plan (“EDCP”) that was adopted in 2001 and subsequently amended. The purpose of the EDCP is to provide current tax planning opportunities as well as supplemental funds upon the retirement or death of certain of our employees. The EDCP is intended to aid in attracting and retaining employees of exceptional ability by providing them with these benefits. We also maintain a Benefit Protection Trust (the “Trust”) that was created to provide a source of funds to assist in meeting the obligations of the EDCP, subject to the claims of our creditors in the event of our insolvency. Assets of the Trust are consolidated in accordance with authoritative guidance. The assets of the Trust consist primarily of mutual fund investments (which are accounted for as trading securities and are marked-to-market on a monthly basis through the consolidated statements of income) and cash and cash equivalents. As such, these assets and obligations are classified within Level 1. (c) Holdings in equity securities of public companies reported in Investments in the consolidated balance sheets. The fair value is measured using publicly available share prices of the investments, with any changes reported in Other income (expense), net, in our consolidated statements of income. (d) Primarily consists of private equity securities reported in Investments in the consolidated balance sheets. The changes in fair value are reported in Other income (expense), net, in our consolidated statements of income. (e) Holdings in certain private equity securities are measured at fair value using the net asset value per share (or its equivalent) practical expedient and have not been categorized in the fair value hierarchy. (f) As a result of our global operating and financing activities, we are exposed to market risks from changes in foreign currency exchange rates which may adversely affect our operating results and financial position. When deemed appropriate, we minimize our risks from foreign currency exchange rate fluctuations through the use of foreign currency forward contracts. The foreign currency forward contracts are valued using broker quotations or market transactions in either the listed or over-the-counter markets. As such, these derivative instruments are classified within Level 2. See Note 14, “Fair Value of Financial Instruments,” for further details about our foreign currency forward contracts. The following tables set forth the reconciliation of the beginning and ending balance for the Level 3 recurring fair value measurements (in thousands): Available for Sale Debt Securities Beginning balance at December 31, 2021 $ 246,517 Fair value adjustment (2,368) Accretion of discount 9,552 Ending balance at September 30, 2022 $ 253,701

Accumulated Other Comprehensive

Accumulated Other Comprehensive (Loss) Income	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Accumulated Other Comprehensive (Loss) Income	Accumulated Other Comprehensive (Loss) Income: The components and activity in Accumulated other comprehensive (loss) income (net of deferred income taxes) consisted of the following during the periods indicated below (in thousands): Foreign Currency Translation and Other Net Investment Hedge (a) Cash Flow Hedge (b) Interest Rate Swap (c) Total Three months ended September 30, 2022 Balance at June 30, 2022 $ (515,269) $ — $ 8,131 $ — $ (507,138) Other comprehensive loss before reclassifications (200,538) — (9,652) — (210,190) Amounts reclassified from accumulated other comprehensive loss 18 — — — 18 Other comprehensive loss, net of tax (200,520) — (9,652) — (210,172) Other comprehensive income attributable to noncontrolling interests 1 — — — 1 Balance at September 30, 2022 $ (715,788) $ — $ (1,521) $ — $ (717,309) Three months ended September 30, 2021 Balance at June 30, 2021 $ (324,951) $ — $ 5,672 $ (8,722) $ (328,001) Other comprehensive (loss) income before reclassifications (39,295) — 214 — (39,081) Amounts reclassified from accumulated other comprehensive loss 21 — — 651 672 Other comprehensive (loss) income, net of tax (39,274) — 214 651 (38,409) Other comprehensive loss attributable to noncontrolling interests (26) — — — (26) Balance at September 30, 2021 $ (364,251) $ — $ 5,886 $ (8,071) $ (366,436) Nine months ended September 30, 2022 Balance at December 31, 2021 $ (391,674) $ — $ 6,623 $ (7,399) $ (392,450) Other comprehensive (loss) income before reclassifications (324,287) — (8,144) — (332,431) Amounts reclassified from accumulated other comprehensive loss 57 — — 7,399 7,456 Other comprehensive (loss) income, net of tax (324,230) — (8,144) 7,399 (324,975) Other comprehensive income attributable to noncontrolling interests 116 — — — 116 Balance at September 30, 2022 $ (715,788) $ — $ (1,521) $ — $ (717,309) Nine months ended September 30, 2021 Balance at December 31, 2020 $ (369,152) $ 46,593 $ 6,449 $ (10,022) $ (326,132) Other comprehensive (loss) income before reclassifications (46,923) 5,110 (563) — (42,376) Amounts reclassified from accumulated other comprehensive loss 71 — — 1,951 2,022 Other comprehensive (loss) income, net of tax (46,852) 5,110 (563) 1,951 (40,354) Amounts reclassified within accumulated other comprehensive loss 51,703 (51,703) — — — Other comprehensive income attributable to noncontrolling interests 50 — — — 50 Balance at September 30, 2021 $ (364,251) $ — $ 5,886 $ (8,071) $ (366,436) (a) During the first quarter of 2021 the net investment hedge was discontinued following the repayment of the 1.875% Euro-denominated senior notes. The balance of foreign exchange revaluation gains and losses associated with this discontinued net investment hedge have been reclassified to Foreign currency translation and other, and will remain within accumulated other comprehensive loss until the hedged net investment is sold or liquidated. (b) We entered into a foreign currency forward contract, which was designated and accounted for as a cash flow hedge under ASC 815, Derivatives and Hedging . See Note 14, “Fair Value of Financial Instruments,” for additional information. (c) The pre-tax portion of amounts reclassified from accumulated other comprehensive loss is included in Interest and financing expenses. The balance of this interest rate swap was being amortized to Interest and financing expenses over the life of the 4.15% senior notes originally due in 2024. As discussed in Note 9, “Long-term Debt,” the Company repaid these notes in the second quarter of 2022, and as a result, reclassified the remaining balance of this interest rate swap to interest expense during the same period as part of the early extinguishment of debt. The amount of income tax (expense) benefit allocated to each component of Other comprehensive (loss) income for the three-month and nine-month periods ended September 30, 2022 and 2021 is provided in the following tables (in thousands): Foreign Currency Translation and Other Net Investment Hedge Cash Flow Hedge Interest Rate Swap Three months ended September 30, 2022 Other comprehensive (loss) income, before tax $ (198,888) $ — $ (9,652) $ — Income tax benefit (expense) (1,632) — — — Other comprehensive (loss) income, net of tax $ (200,520) $ — $ (9,652) $ — Three months ended September 30, 2021 Other comprehensive income (loss), before tax $ (39,266) $ — $ 214 $ 834 Income tax expense (8) — — (183) Other comprehensive income (loss), net of tax $ (39,274) $ — $ 214 $ 651 Nine months ended September 30, 2022 Other comprehensive (loss) income, before tax $ (323,777) $ — $ (8,144) $ 9,739 Income tax benefit (expense) (453) — — (2,340) Other comprehensive (loss) income, net of tax $ (324,230) $ — $ (8,144) $ 7,399 Nine months ended September 30, 2021 Other comprehensive income (loss), before tax $ (46,836) $ 6,552 $ (563) $ 2,502 Income tax expense (16) (1,442) — (551) Other comprehensive income (loss), net of tax $ (46,852) $ 5,110 $ (563) $ 1,951

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions: Our consolidated statements of income include sales to and purchases from unconsolidated affiliates in the ordinary course of business as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Sales to unconsolidated affiliates $ 9,490 $ 5,629 $ 24,359 $ 16,357 Purchases from unconsolidated affiliates (a) $ 614,889 $ 55,540 $ 1,146,329 $ 144,461 (a) Increases in purchases from unconsolidated affiliates primarily relate to increased pricing and volume of spodumene purchased from the Company’s Windfield joint venture. Our consolidated balance sheets include accounts receivable due from and payable to unconsolidated affiliates in the ordinary course of business as follows (in thousands): September 30, 2022 December 31, 2021 Receivables from unconsolidated affiliates $ 3,301 $ 2,139 Payables to unconsolidated affiliates (a) $ 554,845 $ 47,499 (a) Increases in payables to unconsolidated affiliates primarily relate to increased purchases of spodumene purchased from the Company’s joint venture under normal payment terms.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2022
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information: Supplemental information related to the condensed consolidated statements of cash flows is as follows (in thousands): Nine Months Ended 2022 2021 Supplemental non-cash disclosure related to investing and financing activities: Capital expenditures included in Accounts payable $ 253,183 $ 157,743 Promissory note issued for capital expenditures (a) $ 10,876 $ — Non-cash proceeds from divestitures (b) $ — $ 244,530 (a) During the first quarter of 2022, the Company issued a promissory note with a present value of $10.9 million for land purchased in Kings Mountain, NC. The promissory note is payable in equal annual installments from the years 2027 to 2048. (b) Fair value of preferred equity of a Grace subsidiary received as part of the proceeds for the sale of the FCS business. See Note 2, “Divestitures,” for further details. As part of the purchase price paid for the acquisition of a 60% interest in the MRL Wodgina Project, the Company transferred $116.0 million and $135.9 million of its construction in progress of the designated Kemerton assets during the nine months ended September 30, 2022 and 2021, respectively, representing MRL’s 40% interest in the assets. The cash outflow for these assets was recorded in Capital expenditures within Cash flows from investing activities on the condensed consolidated statements of cash flows. The non-cash transfer of these assets is recorded in Non-cash transfer of 40% value of construction in progress of the Kemerton plant to MRL within Cash flows from operating activities on the consolidated statements of cash flows. Other, net within Cash flows from operating activities on the condensed consolidated statements of cash flows for the nine months ended September 30, 2022 and 2021 included $42.5 million and $28.7 million, respectively, representing the reclassification of the current portion of the one-time transition tax resulting from the enactment of the U.S. Tax Cuts and Jobs Act, from Other noncurrent liabilities to Income taxes payable within current liabilities.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	9 Months Ended
	Sep. 30, 2022
Accounting Changes and Error Corrections [Abstract]
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements: In March 2020, the Financial Accounting Standards Board (“FASB”) issued accounting guidance that provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The guidance applies only to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued additional accounting guidance which clarifies that certain optional expedients and exceptions apply to derivatives that are affected by the discounting transition. The guidance under both FASB issuances is effective March 12, 2020 through December 31, 2022. The Company currently does not expect this guidance to have a significant impact on its consolidated financial statements. In November 2021, the FASB issued accounting guidance that requires disclosures about government assistance in the notes to the financial statements. This guidance will require the disclosure of: (1) the types of government assistance received; (2) the accounting for such assistance; and (3) the effect of the assistance on a business entity’s financial statements. This guidance is effective for financial statements issued for annual periods beginning after December 15, 2021. The Company currently does not expect this guidance to have a significant impact on its annual financial statement disclosures. In March 2022, the FASB issued accounting guidance that expands the Company’s abilities to hedge the benchmark interest rate risk of portfolios of financial assets or beneficial interests in a fair value hedge. This guidance expands the use of the portfolio layer method to allow multiple hedges of a single closed portfolio of assets using spot starting, forward starting, and amortizing-notional swaps. This also permits both prepayable and non prepayable financial assets to be included in the closed portfolio of assets hedged in a portfolio layer hedge. In addition, this guidance requires that basis adjustments not be allocated to individual assets for active portfolio layer method hedges, but rather be maintained on the closed portfolio of assets as a whole. This guidance is effective for financial statements issued for annual periods beginning after December 15, 2022, including interim periods within those annual periods. The Company currently does not expect this guidance to have a significant impact on its consolidated financial statements.

Recently Issued Accounting Pr_2

Recently Issued Accounting Pronouncements (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Changes and Error Corrections [Abstract]
Recently Issued Accounting Pronouncements	In March 2020, the Financial Accounting Standards Board (“FASB”) issued accounting guidance that provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The guidance applies only to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued additional accounting guidance which clarifies that certain optional expedients and exceptions apply to derivatives that are affected by the discounting transition. The guidance under both FASB issuances is effective March 12, 2020 through December 31, 2022. The Company currently does not expect this guidance to have a significant impact on its consolidated financial statements. In November 2021, the FASB issued accounting guidance that requires disclosures about government assistance in the notes to the financial statements. This guidance will require the disclosure of: (1) the types of government assistance received; (2) the accounting for such assistance; and (3) the effect of the assistance on a business entity’s financial statements. This guidance is effective for financial statements issued for annual periods beginning after December 15, 2021. The Company currently does not expect this guidance to have a significant impact on its annual financial statement disclosures. In March 2022, the FASB issued accounting guidance that expands the Company’s abilities to hedge the benchmark interest rate risk of portfolios of financial assets or beneficial interests in a fair value hedge. This guidance expands the use of the portfolio layer method to allow multiple hedges of a single closed portfolio of assets using spot starting, forward starting, and amortizing-notional swaps. This also permits both prepayable and non prepayable financial assets to be included in the closed portfolio of assets hedged in a portfolio layer hedge. In addition, this guidance requires that basis adjustments not be allocated to individual assets for active portfolio layer method hedges, but rather be maintained on the closed portfolio of assets as a whole. This guidance is effective for financial statements issued for annual periods beginning after December 15, 2022, including interim periods within those annual periods. The Company currently does not expect this guidance to have a significant impact on its consolidated financial statements.

Goodwill and Other Intangibles

Goodwill and Other Intangibles (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Goodwill	The following table summarizes the changes in goodwill by reportable segment for the nine months ended September 30, 2022 (in thousands): Lithium Bromine Catalysts Total Balance at December 31, 2021 $ 1,394,182 $ 20,319 $ 183,126 $ 1,597,627 Foreign currency translation adjustments (103,887) — (25,892) (129,779) Balance at September 30, 2022 $ 1,290,295 $ 20,319 $ 157,234 $ 1,467,848
Other Intangibles	The following table summarizes the changes in other intangibles and related accumulated amortization for the nine months ended September 30, 2022 (in thousands): Customer Lists and Relationships Trade Names and Trademarks (a) Patents and Technology Other Total Gross Asset Value Balance at December 31, 2021 $ 428,379 $ 17,883 $ 57,313 $ 36,705 $ 540,280 Additions — — — 3,813 3,813 Retirements — (4,253) (16,206) (5,844) (26,303) Foreign currency translation adjustments and other (45,283) (1,300) (4,902) (3,610) (55,095) Balance at September 30, 2022 $ 383,096 $ 12,330 $ 36,205 $ 31,064 $ 462,695 Accumulated Amortization Balance at December 31, 2021 $ (163,283) $ (7,983) $ (39,796) $ (20,271) $ (231,333) Amortization (15,756) — (1,017) (676) (17,449) Retirements — 4,253 16,206 5,844 26,303 Foreign currency translation adjustments and other 17,618 365 3,148 1,637 22,768 Balance at September 30, 2022 $ (161,421) $ (3,365) $ (21,459) $ (13,466) $ (199,711) Net Book Value at December 31, 2021 $ 265,096 $ 9,900 $ 17,517 $ 16,434 $ 308,947 Net Book Value at September 30, 2022 $ 221,675 $ 8,965 $ 14,746 $ 17,598 $ 262,984 (a) Net Book Value includes only indefinite-lived intangible assets.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Calculation of Basic and Diluted Earning Per Share	Basic and diluted earnings per share for the three-month and nine-month periods ended September 30, 2022 and 2021 are calculated as follows (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Basic earnings per share Numerator: Net income (loss) attributable to Albemarle Corporation $ 897,215 $ (392,781) $ 1,557,371 $ 127,496 Denominator: Weighted-average common shares for basic earnings per share 117,136 116,965 117,106 115,455 Basic earnings (loss) per share $ 7.66 $ (3.36) $ 13.30 $ 1.10 Diluted earnings per share Numerator: Net income (loss) attributable to Albemarle Corporation $ 897,215 $ (392,781) $ 1,557,371 $ 127,496 Denominator: Weighted-average common shares for basic earnings per share 117,136 116,965 117,106 115,455 Incremental shares under stock compensation plans 733 — 643 685 Weighted-average common shares for diluted earnings per share 117,869 116,965 117,749 116,140 Diluted earnings (loss) per share $ 7.61 $ (3.36) $ 13.23 $ 1.10

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Breakdown of Inventories	The following table provides a breakdown of inventories at September 30, 2022 and December 31, 2021 (in thousands): September 30, December 31, 2022 2021 Finished goods $ 1,244,674 $ 459,536 Raw materials and work in process (a) 277,594 259,221 Stores, supplies and other 92,031 79,863 Total $ 1,614,299 $ 798,620 (a) Included $132.1 million and $149.4 million at September 30, 2022 and December 31, 2021, respectively, of work in process in our Lithium segment.

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Long-term Debt	Long-term debt at September 30, 2022 and December 31, 2021 consisted of the following (in thousands): September 30, December 31, 2022 2021 1.125% notes due 2025 $ 361,818 $ 426,571 1.625% notes due 2028 479,700 565,550 3.45% Senior notes due 2029 171,612 171,612 4.15% Senior notes due 2024 — 425,000 4.65% Senior notes due 2027 650,000 — 5.05% Senior notes due 2032 600,000 — 5.45% Senior notes due 2044 350,000 350,000 5.65% Senior notes due 2052 450,000 — Credit facilities 250,000 — Commercial paper notes — 388,500 Variable-rate foreign bank loans 2,763 5,226 Finance lease obligations 71,975 75,431 Other 11,252 — Unamortized discount and debt issuance costs (29,151) (13,651) Total long-term debt 3,369,969 2,394,239 Less amounts due within one year 251,216 389,920 Long-term debt, less current portion $ 3,118,753 $ 2,004,319

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Activity in Recorded Environmental Liabilities	The following activity was recorded in environmental liabilities for the nine months ended September 30, 2022 (in thousands): Beginning balance at December 31, 2021 $ 46,617 Expenditures (2,495) Accretion of discount 777 Additions and changes in estimates 2,811 Foreign currency translation adjustments and other (3,533) Ending balance at September 30, 2022 44,177 Less amounts reported in Accrued expenses 9,496 Amounts reported in Other noncurrent liabilities $ 34,681

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Lease, Cost	The following table provides details of our lease contracts for the three-month and nine-month periods ended September 30, 2022 and 2021 (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Operating lease cost $ 11,456 $ 13,807 $ 32,657 $ 32,954 Finance lease cost: Amortization of right of use assets 952 153 2,354 466 Interest on lease liabilities 826 722 2,519 2,229 Total finance lease cost 1,778 875 4,873 2,695 Short-term lease cost 4,171 2,949 10,141 7,729 Variable lease cost 3,179 2,441 5,810 6,619 Total lease cost $ 20,584 $ 20,072 $ 53,481 $ 49,997 Supplemental cash flow information related to our lease contracts for the nine-month periods ended September 30, 2022 and 2021 is as follows (in thousands): Nine Months Ended September 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 27,201 $ 24,462 Operating cash flows from finance leases 2,360 1,295 Financing cash flows from finance leases 999 471 Right-of-use assets obtained in exchange for lease obligations: Operating leases 8,378 57,136
Supplemental Balance Sheet Information related to Leases	Supplemental balance sheet information related to our lease contracts, including the location on balance sheet, at September 30, 2022 and December 31, 2021 is as follows (in thousands, except as noted): September 30, 2022 December 31, 2021 Operating leases: Other assets $ 130,257 $ 154,741 Accrued expenses 30,039 31,603 Other noncurrent liabilities 102,198 126,997 Total operating lease liabilities 132,237 158,600 Finance leases: Net property, plant and equipment 70,968 75,302 Current portion of long-term debt (a) 3,723 3,768 Long-term debt 70,758 74,011 Total finance lease liabilities 74,481 77,779 Weighted average remaining lease term (in years): Operating leases 13.7 12.9 Finance leases 24.5 24.5 Weighted average discount rate (%): Operating leases 3.60 % 3.44 % Finance leases 4.41 % 4.47 % (a) Balance includes accrued interest of finance lease recorded in Accrued liabilities.
Lessee, Operating Lease, Liability, Maturity	Maturities of lease liabilities at September 30, 2022 were as follows (in thousands): Operating Leases Finance Leases Remainder of 2022 $ 9,376 $ 1,470 2023 33,845 5,879 2024 21,552 5,879 2025 12,328 5,879 2026 9,977 5,303 Thereafter 121,460 96,580 Total lease payments 208,538 120,990 Less imputed interest 76,301 46,509 Total $ 132,237 $ 74,481
Finance Lease, Liability, Maturity	Maturities of lease liabilities at September 30, 2022 were as follows (in thousands): Operating Leases Finance Leases Remainder of 2022 $ 9,376 $ 1,470 2023 33,845 5,879 2024 21,552 5,879 2025 12,328 5,879 2026 9,977 5,303 Thereafter 121,460 96,580 Total lease payments 208,538 120,990 Less imputed interest 76,301 46,509 Total $ 132,237 $ 74,481

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Reportable Segments Summarized Financial Information	Three Months Ended Nine Months Ended 2022 2021 2022 2021 (In thousands) (In thousands) Net sales: Lithium $ 1,501,073 $ 359,229 $ 2,942,861 $ 958,539 Bromine 354,908 277,783 1,092,239 837,978 Catalysts 235,824 193,554 664,026 562,141 All Other — — — 75,095 Total net sales $ 2,091,805 $ 830,566 $ 4,699,126 $ 2,433,753 Adjusted EBITDA: Lithium $ 1,111,243 $ 125,416 $ 1,915,066 $ 341,293 Bromine 106,958 86,012 371,875 273,298 Catalysts 4,635 33,103 31,337 79,694 All Other — — — 29,858 Corporate (32,870) (26,962) (86,173) (81,892) Total adjusted EBITDA $ 1,189,966 $ 217,569 $ 2,232,105 $ 642,251 See below for a reconciliation of adjusted EBITDA, a non-GAAP financial measure, from Net (loss) income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands): Lithium Bromine Catalysts All Other Corporate Consolidated Total Three months ended September 30, 2022 Net income (loss) attributable to Albemarle Corporation $ 1,063,426 $ 93,186 $ (12,473) $ — $ (246,924) $ 897,215 Depreciation and amortization 47,758 13,772 12,689 — 3,494 77,713 Acquisition and integration related costs (a) — — — — 2,145 2,145 Interest and financing expenses — — — — 29,691 29,691 Income tax expense — — — — 196,938 196,938 Non-operating pension and OPEB items — — — — (5,027) (5,027) Other (b) 59 — 4,419 — (13,187) (8,709) Adjusted EBITDA $ 1,111,243 $ 106,958 $ 4,635 $ — $ (32,870) $ 1,189,966 Three months ended September 30, 2021 Net income (loss) attributable to Albemarle Corporation $ 92,449 $ 73,409 $ 20,039 $ — $ (578,678) $ (392,781) Depreciation and amortization 34,256 12,603 13,064 — 2,159 62,082 Restructuring and other (c) — — — — 754 754 Gain on sale of business (d) — — — — 984 984 Acquisition and integration related costs (a) — — — — 1,553 1,553 Interest and financing expenses — — — — 5,136 5,136 Income tax expense — — — — (114,670) (114,670) Non-operating pension and OPEB items — — — — (5,471) (5,471) Legal accrual (e) — — — — 657,412 657,412 Other (f) (1,289) — — — 3,859 2,570 Adjusted EBITDA $ 125,416 $ 86,012 $ 33,103 $ — $ (26,962) $ 217,569 Nine months ended September 30, 2022 Net income (loss) attributable to Albemarle Corporation $ 1,777,214 $ 332,208 $ (11,867) $ — $ (540,184) $ 1,557,371 Depreciation and amortization 128,786 39,667 38,785 — 8,042 215,280 Loss on sale of interest in properties (g) 8,400 — — — — 8,400 Acquisition and integration related costs (a) — — — — 9,244 9,244 Interest and financing expenses (h) — — — — 98,934 98,934 Income tax expense — — — — 366,486 366,486 Non-operating pension and OPEB items — — — — (15,345) (15,345) Other (b) 666 — 4,419 — (13,350) (8,265) Adjusted EBITDA $ 1,915,066 $ 371,875 $ 31,337 $ — $ (86,173) $ 2,232,105 Nine months ended September 30, 2021 Net income (loss) attributable to Albemarle Corporation $ 237,293 $ 235,670 $ 41,401 $ 27,988 $ (414,856) $ 127,496 Depreciation and amortization 99,559 37,628 38,293 1,870 8,415 185,765 Restructuring and other (c) — — — — 2,294 2,294 Gain on sale of business (d) — — — — (428,424) (428,424) Acquisition and integration related costs (a) — — — — 5,629 5,629 Interest and financing expenses (h) — — — — 56,170 56,170 Income tax expense — — — — 14,422 14,422 Non-operating pension and OPEB items — — — — (16,407) (16,407) Legal accrual (e) — — — — 657,412 657,412 Albemarle Foundation contribution (i) — — — — 20,000 20,000 Other (f) 4,441 — — — 13,453 17,894 Adjusted EBITDA $ 341,293 $ 273,298 $ 79,694 $ 29,858 $ (81,892) $ 642,251 (a) Costs related to the acquisition, integration and potential divestitures for various significant projects, recorded in Selling, general and administrative expenses (“SG&A”). (b) Included amounts for the three months ended September 30, 2022 recorded in: • Cost of goods sold - $2.7 million of expense related to one-time retention payments for certain employees during the Catalysts strategic review and business unit realignment. • SG&A - $1.9 million of expense primarily related to one-time retention payments for certain employees during the Catalysts strategic review and business unit realignment and $1.3 million primarily related to facility closure expenses of offices in Germany. • Other income, net - $10.6 million net gain related to the fair value adjustment of equity securities in a public company, a $3.0 million gain from the reversal of a liability related to a previous divestiture and $1.1 million of gain resulting from the adjustment of indemnification related to previously disposed businesses. Included amounts for the nine months ended September 30, 2022 recorded in: • Cost of goods sold - $2.7 million of expense related to one-time retention payments for certain employees during the Catalysts strategic review and business unit realignment, and $0.5 million related to the settlement of a legal matter resulting from a prior acquisition. • SG&A - $3.2 million primarily related to facility closure expenses of offices in Germany, $2.8 million of charges for environmental reserves at sites not part of our operations and $1.9 million of expense primarily related to one-time retention payments for certain employees during the Catalysts strategic review, partially offset by $4.3 million of gains from the sale of legacy properties not part of our operations. • Other income, net - $10.6 million net gain related to the fair value adjustment of equity securities in a public company, a $3.0 million gain from the reversal of a liability related to a previous divestiture, $1.1 million of gain resulting from the adjustment of indemnification related to previously disposed businesses and a $0.6 million gain related to a settlement received from a legal matter in a prior period. (c) In 2021, the Company recorded facility closure related to offices in Germany, and severance expenses in Germany and Belgium, in SG&A. (d) See Note 3, “Divestitures,” for additional information. (e) Loss recorded in Other expense, net in the three and nine months ended September 30, 2021 related to the settlement of an arbitration ruling for a prior legal matter. See Note 10, “Commitments and Contingencies,” for further details. (f) Included amounts for the three months ended September 30, 2021 recorded in: • SG&A - $2.5 million of expenses primarily related to non-routine labor and compensation related costs that are outside normal compensation arrangements. • Other income, net - $0.1 million of loss resulting from the adjustment of indemnification related to previously disposed businesses. Included amounts for the nine months ended September 30, 2021 recorded in: • SG&A - $8.6 million of expenses primarily related to non-routine labor and compensation related costs that are outside normal compensation arrangements, a $4.0 million loss resulting from the sale of property, plant and equipment and $1.6 million of charges for an environmental reserve at a site not part of our operations. • Other income, net - $3.7 million of expenses primarily related to asset retirement obligation charges to update of an estimate at a site formerly owned by Albemarle. (g) Expense recorded as a result of revised estimates of the obligation to construct certain lithium hydroxide conversion assets in Kemerton, Western Australia, due to cost overruns from supply chain, labor and COVID-19 pandemic related issues. The corresponding obligation was recorded in Accrued liabilities to be transferred to Mineral Resources Limited (“MRL”), which maintains a 40% ownership interest in these Kemerton assets. (h) Included in Interest and financing expenses is a loss on early extinguishment of debt of $19.2 million and $29.0 million for the nine months ended September 30, 2022 and 2021, respectively. See Note 9, “Long-term Debt,” for additional information. In addition, Interest and financing expenses for the nine months ended September 30, 2022 includes the correction of an out of period error of $17.5 million related to the overstatement of capitalized interest in prior periods. See Note 1, “Basis of Presentation,” for further details. (i) Included in SG&A is a charitable contribution, using a portion of the proceeds received from the FCS divestiture, to the Albemarle Foundation, a non-profit organization that sponsors grants, health and social projects, educational initiatives, disaster relief, matching gift programs, scholarships and other charitable initiatives in locations where the Company’s employees live and the Company operates. This contribution is in addition to the normal annual contribution made to the Albemarle Foundation by the Company, and is significant in size and nature in that it is intended to provide more long-term benefits in these communities.

Pension Plans and Other Postr_2

Pension Plans and Other Postretirement Benefits (Tables)	9 Months Ended
	Sep. 30, 2022
Retirement Benefits [Abstract]
Domestic and Foreign Pension and Postretirement Defined Benefit Plans	The components of pension and postretirement benefits cost (credit) for the three-month and nine-month periods ended September 30, 2022 and 2021 were as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Pension Benefits Cost (Credit): Service cost $ 959 $ 1,425 $ 2,914 $ 3,776 Interest cost 5,530 5,113 16,703 15,352 Expected return on assets (10,884) (10,893) (33,028) (32,687) Amortization of prior service benefit 21 29 68 87 Total net pension benefits credit $ (4,374) $ (4,326) $ (13,343) $ (13,472) Postretirement Benefits Cost: Service cost $ 21 $ 31 $ 64 $ 93 Interest cost 327 309 980 928 Total net postretirement benefits cost $ 348 $ 340 $ 1,044 $ 1,021 Total net pension and postretirement benefits credit $ (4,026) $ (3,986) $ (12,299) $ (12,451)

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value of Long-Term Debt	The carrying value of our remaining long-term debt reported in the accompanying consolidated balance sheets approximates fair value as substantially all of such debt bears interest based on prevailing variable market rates currently available in the countries in which we have borrowings. September 30, 2022 December 31, 2021 Recorded Fair Value Recorded Fair Value (In thousands) Long-term debt $ 3,393,136 $ 3,091,805 $ 2,405,021 $ 2,593,590
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The following table summarizes the fair value of our foreign currency forward contracts included in the consolidated balance sheets as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 December 31, 2021 Assets Liabilities Assets Liabilities Designated as hedging instruments Other current assets $ — $ — $ 237 $ — Accrued expenses — 9,169 — 57 Total designated as hedging instruments — 9,169 237 57 Not designated as hedging instruments Other current assets 4,968 — 2,901 — Accrued expenses — 50 — 248 Total not designated as hedging instruments 4,968 50 2,901 248 Total $ 4,968 $ 9,219 $ 3,138 $ 305
Derivative Instruments, Losses	The following table summarizes the net gains (losses) recognized for our foreign currency forward contracts during the three-month and nine-month periods ended September 30, 2022 and 2021 (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Designated as hedging instruments (Loss) income recognized in Other comprehensive loss $ (9,653) $ 214 $ (8,144) $ (563) Not designated as hedging instruments (Loss) income recognized in Other income, net (a) $ (9,056) $ (1,199) $ (36,326) $ 658 (a) Fluctuations in the value of our foreign currency forward contracts not designated as hedging instruments are generally expected to be offset by changes in the value of the underlying exposures being hedged, which are also reported in Other income, net.

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities Accounted for at Fair Value on Recurring Basis	The following tables set forth our financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 Quoted Prices in Active Markets for Identical Items (Level 1) Quoted Prices in Active Markets for Similar Items (Level 2) Unobservable Inputs (Level 3) Assets: Available for sale debt securities (a) $ 253,701 $ — $ — $ 253,701 Investments under executive deferred compensation plan (b) $ 25,495 $ 25,495 $ — $ — Public equity securities (c) $ 12,197 $ 12,197 $ — $ — Private equity securities measured at net asset value (d)(e) $ 4,716 $ — $ — $ — Foreign currency forward contracts (f) $ 4,968 $ — $ 4,968 $ — Liabilities: Obligations under executive deferred compensation plan (b) $ 25,495 $ 25,495 $ — $ — Foreign currency forward contracts (f) $ 9,219 $ — $ 9,219 $ — December 31, 2021 Quoted Prices in Active Markets for Identical Items (Level 1) Quoted Prices in Active Markets for Similar Items (Level 2) Unobservable Inputs (Level 3) Assets: Available for sale debt securities (a) $ 246,517 $ — $ — $ 246,517 Investments under executive deferred compensation plan (b) $ 32,491 $ 32,491 $ — $ — Private equity securities measured at net asset value (d)(e) $ 4,696 $ — $ — $ — Foreign currency forward contracts (f) $ 3,138 $ — $ 3,138 $ — Liabilities: Obligations under executive deferred compensation plan (b) $ 32,491 $ 32,491 $ — $ — Foreign currency forward contracts (f) $ 305 $ — $ 305 $ — (a) Preferred equity of a Grace subsidiary acquired as a portion of the proceeds of the FCS sale on June 1, 2021. See Note 2, “Divestitures,” for further details on the material terms and conditions. A third-party estimate of the fair value was prepared using expected future cash flows over the period up to when the asset is likely to be redeemed, applying a discount rate that appropriately captures a market participant's view of the risk associated with the investment. These are considered to be Level 3 inputs. (b) We maintain an Executive Deferred Compensation Plan (“EDCP”) that was adopted in 2001 and subsequently amended. The purpose of the EDCP is to provide current tax planning opportunities as well as supplemental funds upon the retirement or death of certain of our employees. The EDCP is intended to aid in attracting and retaining employees of exceptional ability by providing them with these benefits. We also maintain a Benefit Protection Trust (the “Trust”) that was created to provide a source of funds to assist in meeting the obligations of the EDCP, subject to the claims of our creditors in the event of our insolvency. Assets of the Trust are consolidated in accordance with authoritative guidance. The assets of the Trust consist primarily of mutual fund investments (which are accounted for as trading securities and are marked-to-market on a monthly basis through the consolidated statements of income) and cash and cash equivalents. As such, these assets and obligations are classified within Level 1. (c) Holdings in equity securities of public companies reported in Investments in the consolidated balance sheets. The fair value is measured using publicly available share prices of the investments, with any changes reported in Other income (expense), net, in our consolidated statements of income. (d) Primarily consists of private equity securities reported in Investments in the consolidated balance sheets. The changes in fair value are reported in Other income (expense), net, in our consolidated statements of income. (e) Holdings in certain private equity securities are measured at fair value using the net asset value per share (or its equivalent) practical expedient and have not been categorized in the fair value hierarchy. (f) As a result of our global operating and financing activities, we are exposed to market risks from changes in foreign currency exchange rates which may adversely affect our operating results and financial position. When deemed appropriate, we minimize our risks from foreign currency exchange rate fluctuations through the use of foreign currency forward contracts. The foreign currency forward contracts are valued using broker quotations or market transactions in either the listed or over-the-counter markets. As such, these derivative instruments are classified within Level 2. See Note 14, “Fair Value of Financial Instruments,” for further details about our foreign currency forward contracts.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	The following tables set forth the reconciliation of the beginning and ending balance for the Level 3 recurring fair value measurements (in thousands): Available for Sale Debt Securities Beginning balance at December 31, 2021 $ 246,517 Fair value adjustment (2,368) Accretion of discount 9,552 Ending balance at September 30, 2022 $ 253,701

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive (Loss) Income (Tables)	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Components and Activity in Accumulated Other Comprehensive (Loss) Income Net of Deferred Income Taxes	The components and activity in Accumulated other comprehensive (loss) income (net of deferred income taxes) consisted of the following during the periods indicated below (in thousands): Foreign Currency Translation and Other Net Investment Hedge (a) Cash Flow Hedge (b) Interest Rate Swap (c) Total Three months ended September 30, 2022 Balance at June 30, 2022 $ (515,269) $ — $ 8,131 $ — $ (507,138) Other comprehensive loss before reclassifications (200,538) — (9,652) — (210,190) Amounts reclassified from accumulated other comprehensive loss 18 — — — 18 Other comprehensive loss, net of tax (200,520) — (9,652) — (210,172) Other comprehensive income attributable to noncontrolling interests 1 — — — 1 Balance at September 30, 2022 $ (715,788) $ — $ (1,521) $ — $ (717,309) Three months ended September 30, 2021 Balance at June 30, 2021 $ (324,951) $ — $ 5,672 $ (8,722) $ (328,001) Other comprehensive (loss) income before reclassifications (39,295) — 214 — (39,081) Amounts reclassified from accumulated other comprehensive loss 21 — — 651 672 Other comprehensive (loss) income, net of tax (39,274) — 214 651 (38,409) Other comprehensive loss attributable to noncontrolling interests (26) — — — (26) Balance at September 30, 2021 $ (364,251) $ — $ 5,886 $ (8,071) $ (366,436) Nine months ended September 30, 2022 Balance at December 31, 2021 $ (391,674) $ — $ 6,623 $ (7,399) $ (392,450) Other comprehensive (loss) income before reclassifications (324,287) — (8,144) — (332,431) Amounts reclassified from accumulated other comprehensive loss 57 — — 7,399 7,456 Other comprehensive (loss) income, net of tax (324,230) — (8,144) 7,399 (324,975) Other comprehensive income attributable to noncontrolling interests 116 — — — 116 Balance at September 30, 2022 $ (715,788) $ — $ (1,521) $ — $ (717,309) Nine months ended September 30, 2021 Balance at December 31, 2020 $ (369,152) $ 46,593 $ 6,449 $ (10,022) $ (326,132) Other comprehensive (loss) income before reclassifications (46,923) 5,110 (563) — (42,376) Amounts reclassified from accumulated other comprehensive loss 71 — — 1,951 2,022 Other comprehensive (loss) income, net of tax (46,852) 5,110 (563) 1,951 (40,354) Amounts reclassified within accumulated other comprehensive loss 51,703 (51,703) — — — Other comprehensive income attributable to noncontrolling interests 50 — — — 50 Balance at September 30, 2021 $ (364,251) $ — $ 5,886 $ (8,071) $ (366,436) (a) During the first quarter of 2021 the net investment hedge was discontinued following the repayment of the 1.875% Euro-denominated senior notes. The balance of foreign exchange revaluation gains and losses associated with this discontinued net investment hedge have been reclassified to Foreign currency translation and other, and will remain within accumulated other comprehensive loss until the hedged net investment is sold or liquidated. (b) We entered into a foreign currency forward contract, which was designated and accounted for as a cash flow hedge under ASC 815, Derivatives and Hedging . See Note 14, “Fair Value of Financial Instruments,” for additional information. (c) The pre-tax portion of amounts reclassified from accumulated other comprehensive loss is included in Interest and financing expenses. The balance of this interest rate swap was being amortized to Interest and financing expenses over the life of the 4.15% senior notes originally due in 2024. As discussed in Note 9, “Long-term Debt,” the Company repaid these notes in the second quarter of 2022, and as
Amount of Income Tax (Expense) Benefit Allocated to Component Of Other Comprehensive Income (Loss)	The amount of income tax (expense) benefit allocated to each component of Other comprehensive (loss) income for the three-month and nine-month periods ended September 30, 2022 and 2021 is provided in the following tables (in thousands): Foreign Currency Translation and Other Net Investment Hedge Cash Flow Hedge Interest Rate Swap Three months ended September 30, 2022 Other comprehensive (loss) income, before tax $ (198,888) $ — $ (9,652) $ — Income tax benefit (expense) (1,632) — — — Other comprehensive (loss) income, net of tax $ (200,520) $ — $ (9,652) $ — Three months ended September 30, 2021 Other comprehensive income (loss), before tax $ (39,266) $ — $ 214 $ 834 Income tax expense (8) — — (183) Other comprehensive income (loss), net of tax $ (39,274) $ — $ 214 $ 651 Nine months ended September 30, 2022 Other comprehensive (loss) income, before tax $ (323,777) $ — $ (8,144) $ 9,739 Income tax benefit (expense) (453) — — (2,340) Other comprehensive (loss) income, net of tax $ (324,230) $ — $ (8,144) $ 7,399 Nine months ended September 30, 2021 Other comprehensive income (loss), before tax $ (46,836) $ 6,552 $ (563) $ 2,502 Income tax expense (16) (1,442) — (551) Other comprehensive income (loss), net of tax $ (46,852) $ 5,110 $ (563) $ 1,951

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	Our consolidated statements of income include sales to and purchases from unconsolidated affiliates in the ordinary course of business as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Sales to unconsolidated affiliates $ 9,490 $ 5,629 $ 24,359 $ 16,357 Purchases from unconsolidated affiliates (a) $ 614,889 $ 55,540 $ 1,146,329 $ 144,461 (a) Increases in purchases from unconsolidated affiliates primarily relate to increased pricing and volume of spodumene purchased from the Company’s Windfield joint venture. Our consolidated balance sheets include accounts receivable due from and payable to unconsolidated affiliates in the ordinary course of business as follows (in thousands): September 30, 2022 December 31, 2021 Receivables from unconsolidated affiliates $ 3,301 $ 2,139 Payables to unconsolidated affiliates (a) $ 554,845 $ 47,499 (a) Increases in payables to unconsolidated affiliates primarily relate to increased purchases of spodumene purchased from the Company’s joint venture under normal payment terms.

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2022
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	Supplemental information related to the condensed consolidated statements of cash flows is as follows (in thousands): Nine Months Ended 2022 2021 Supplemental non-cash disclosure related to investing and financing activities: Capital expenditures included in Accounts payable $ 253,183 $ 157,743 Promissory note issued for capital expenditures (a) $ 10,876 $ — Non-cash proceeds from divestitures (b) $ — $ 244,530 (a) During the first quarter of 2022, the Company issued a promissory note with a present value of $10.9 million for land purchased in Kings Mountain, NC. The promissory note is payable in equal annual installments from the years 2027 to 2048. (b) Fair value of preferred equity of a Grace subsidiary received as part of the proceeds for the sale of the FCS business. See Note 2, “Divestitures,” for further details.

Basis of Presentation (Details)

Basis of Presentation (Details) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended
	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Mar. 31, 2021	Mar. 31, 2020	Sep. 30, 2022	Sep. 30, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Interest and Debt Expense	$ (29,691)		$ (5,136)			$ (98,934)	$ (56,170)
Out-of-period adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Interest and Debt Expense		$ 11,400		$ 5,500	$ 600
Revision of Prior Period, Error Correction, Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Interest and Debt Expense						$ 17,500

Business Combinations and Ass_2

Business Combinations and Asset Acquisitions (Details) - Guangxi Tianyuan New Energy Materials Co Ltd	9 Months Ended
	Sep. 30, 2022 USD ($) metricTon
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross | $	$ 200,000,000
Designed Annual Conversion Capacity | metricTon	25,000

Assets and Liabilities Held for

Assets and Liabilities Held for Sale (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Feb. 25, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain (Loss) on Disposition of Business		$ 0	$ (984)	$ (8,400)	$ 428,424
Fine Chemistry Services
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Non-cash proceeds from divestitures	$ 570,000
Cash Proceeds from Divestiture	300,000
Preferred Stock, Value, Outstanding	$ 270,000	$ 253,700		$ 253,700		$ 246,500
Preferred Stock, Dividend Rate, Percentage	12%
Gain (Loss) on Disposition of Business			428,400		428,400
Gain (Loss) on Disposition of Business, net of tax			$ (330,900)		$ (330,900)

Goodwill and Other Intangible_2

Goodwill and Other Intangibles - Changes in Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Goodwill [Roll Forward]
Balance at beginning of period	$ 1,597,627
Foreign currency translation adjustments	(129,779)
Balance at end of period	1,467,848
Reportable Segments | Lithium
Goodwill [Roll Forward]
Balance at beginning of period	1,394,182
Foreign currency translation adjustments	(103,887)
Balance at end of period	1,290,295
Reportable Segments | Bromine
Goodwill [Roll Forward]
Balance at beginning of period	20,319
Foreign currency translation adjustments	0
Balance at end of period	20,319
Reportable Segments | Catalysts
Goodwill [Roll Forward]
Balance at beginning of period	183,126
Foreign currency translation adjustments	(25,892)
Balance at end of period	$ 157,234

Goodwill and Other Intangible_3

Goodwill and Other Intangibles - Other Intangibles (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Asset Value, Beginning of Period	$ 540,280
Foreign currency translation adjustments and other	(55,095)
Gross Asset Value, End of Period	462,695
Finite-Lived Intangible Assets, Additions	3,813
Finite-Lived Intangible Assets Acquired	26,303
Accumulated Amortization, Beginning of Period	(231,333)
Amortization	(17,449)
Finite-Lived Intangible Assets Accumulated Amortization, Retirements	26,303
Foreign currency translation adjustments and other	22,768
Accumulated Amortization, End of Period	(199,711)
Net Book Value	262,984	$ 308,947
Customer lists and relationships
Finite-Lived Intangible Assets [Line Items]
Gross Asset Value, Beginning of Period	428,379
Foreign currency translation adjustments and other	(45,283)
Gross Asset Value, End of Period	383,096
Finite-Lived Intangible Assets, Additions	0
Finite-Lived Intangible Assets Acquired	0
Accumulated Amortization, Beginning of Period	(163,283)
Amortization	(15,756)
Finite-Lived Intangible Assets Accumulated Amortization, Retirements	0
Foreign currency translation adjustments and other	17,618
Accumulated Amortization, End of Period	(161,421)
Net Book Value	221,675	265,096
Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Asset Value, Beginning of Period	17,883
Foreign currency translation adjustments and other	(1,300)
Gross Asset Value, End of Period	12,330
Finite-Lived Intangible Assets, Additions	0
Finite-Lived Intangible Assets Acquired	4,253
Accumulated Amortization, Beginning of Period	(7,983)
Amortization	0
Finite-Lived Intangible Assets Accumulated Amortization, Retirements	4,253
Foreign currency translation adjustments and other	365
Accumulated Amortization, End of Period	(3,365)
Net Book Value	8,965	9,900
Patents and technology
Finite-Lived Intangible Assets [Line Items]
Gross Asset Value, Beginning of Period	57,313
Foreign currency translation adjustments and other	(4,902)
Gross Asset Value, End of Period	36,205
Finite-Lived Intangible Assets, Additions	0
Finite-Lived Intangible Assets Acquired	16,206
Accumulated Amortization, Beginning of Period	(39,796)
Amortization	(1,017)
Finite-Lived Intangible Assets Accumulated Amortization, Retirements	16,206
Foreign currency translation adjustments and other	3,148
Accumulated Amortization, End of Period	(21,459)
Net Book Value	14,746	17,517
Other
Finite-Lived Intangible Assets [Line Items]
Gross Asset Value, Beginning of Period	36,705
Foreign currency translation adjustments and other	(3,610)
Gross Asset Value, End of Period	31,064
Finite-Lived Intangible Assets, Additions	3,813
Finite-Lived Intangible Assets Acquired	5,844
Accumulated Amortization, Beginning of Period	(20,271)
Amortization	(676)
Finite-Lived Intangible Assets Accumulated Amortization, Retirements	5,844
Foreign currency translation adjustments and other	1,637
Accumulated Amortization, End of Period	(13,466)
Net Book Value	$ 17,598	$ 16,434

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Effective income tax rate	22.70%	22.20%	23.30%	10.20%
Income Tax Expense (Benefit), Gain On Sale of Business		$ 97.5		$ 97.5
Income Tax Expense (Benefit), Legal Accrual		$ 152.9		$ 152.9

Earnings Per Share - Calculatio

Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share From Continuing Operations (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Basic earnings per share from continuing operations
Net income attributable to Albemarle Corporation	$ 897,215	$ (392,781)	$ 1,557,371	$ 127,496
Weighted-average common shares for basic earnings per share (in shares)	117,136	116,965	117,106	115,455
Basic earnings per share (in dollars per share)	$ 7.66	$ (3.36)	$ 13.30	$ 1.10
Diluted earnings per share from continuing operations
Net income attributable to Albemarle Corporation	$ 897,215	$ (392,781)	$ 1,557,371	$ 127,496
Weighted-average common shares for basic earnings per share (in shares)	117,136	116,965	117,106	115,455
Incremental shares under stock compensation plans (in shares)	733	0	643	685
Weighted-average common shares outstanding - diluted (in shares)	117,869	116,965	117,749	116,140
Diluted earnings per share (in dollars per share)	$ 7.61	$ (3.36)	$ 13.23	$ 1.10

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended
	Feb. 08, 2021	Sep. 30, 2022	Sep. 30, 2021	Jul. 18, 2022	May 03, 2022	Dec. 31, 2021
Earnings Per Share [Abstract]
Issuance of common stock, net (in shares)	8,496,773
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01				$ 0.01
Stock Issued During Period Value Per Share New Issues	$ 153
Stock Issued During Period Shares New Issues Underwriter Option	1,274,509
Issuance of common stock, net	$ 1,500,000	$ 387	$ 1,453,888
Cash dividend, amount per share (in dollars per share)				$ 0.395	$ 0.395

Inventories - Breakdown of inve

Inventories - Breakdown of inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Finished goods	$ 1,244,674	$ 459,536
Raw materials and work in process	277,594	259,221
Stores, supplies and other	92,031	79,863
Total inventories	$ 1,614,299	$ 798,620

Inventories - Additional Inform

Inventories - Additional Information (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Lithium
Inventory [Line Items]
Work in process related to Lithium	$ 132.1	$ 149.4

Investments (Details)

Investments (Details) - USD ($) $ in Millions		9 Months Ended	12 Months Ended
	Feb. 25, 2021	Sep. 30, 2022	Dec. 31, 2021
Fine Chemistry Services
Schedule of Investments [Line Items]
Preferred Stock, Value, Outstanding	$ 270	$ 253.7	$ 246.5
Preferred Stock, Dividend Rate, Percentage	12%
Windfield Holdings
Schedule of Investments [Line Items]
Carrying value of unconsolidated investment		$ 706.5	476.6
Windfield Holdings | Windfield Holdings
Schedule of Investments [Line Items]
Equity method investment, ownership percentage		49%
Other variable interest entities
Schedule of Investments [Line Items]
Carrying value of unconsolidated investment		$ 7.2	8
Equity Method Investment, Deferred Gain on Sale		$ 222.1	$ 14.3

Long-Term Debt (Details)

Long-Term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	May 13, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Total long-term Debt	$ 3,369,969		$ 2,394,239
Unamortized discount and debt issuance costs	(29,151)		(13,651)
Current portion of long-term debt	251,216		389,920
Long-term debt	$ 3,118,753		2,004,319
1.875% Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate	1.875%
Unsecured debt | 1.125% Notes
Debt Instrument [Line Items]
Total long-term Debt	$ 361,818		$ 426,571
Debt instrument, interest rate	1.125%		1.125%
Unsecured debt | 1.625% Notes
Debt Instrument [Line Items]
Total long-term Debt	$ 479,700		$ 565,550
Debt instrument, interest rate	1.625%		1.625%
Senior notes | 3.45% Senior Notes
Debt Instrument [Line Items]
Total long-term Debt	$ 171,612		$ 171,612
Debt instrument, interest rate	3.45%		3.45%
Senior notes | 4.15% Senior Notes
Debt Instrument [Line Items]
Total long-term Debt	$ 0		$ 425,000
Debt instrument, interest rate	4.15%		4.15%
Senior notes | 5.45% Senior Notes
Debt Instrument [Line Items]
Total long-term Debt	$ 350,000		$ 350,000
Debt instrument, interest rate	5.45%		5.45%
Senior notes | Four Point Six Five Percent Senior Notes
Debt Instrument [Line Items]
Total long-term Debt	$ 650,000		$ 0
Debt instrument, interest rate	4.65%	4.65%	4.65%
Senior notes | Five Point Zero Five Percent Senior Notes
Debt Instrument [Line Items]
Total long-term Debt	$ 600,000		$ 0
Debt instrument, interest rate	5.05%	5.05%	5.05%
Senior notes | Five Point Six Five Percent Senior Notes
Debt Instrument [Line Items]
Total long-term Debt	$ 450,000		$ 0
Debt instrument, interest rate	5.65%	5.65%	5.65%
Credit facilities
Debt Instrument [Line Items]
Total long-term Debt	$ 250,000		$ 0
Commercial paper notes
Debt Instrument [Line Items]
Total long-term Debt	0		388,500
Variable-rate foreign bank loans
Debt Instrument [Line Items]
Total long-term Debt	2,763		5,226
Finance lease obligations
Debt Instrument [Line Items]
Total long-term Debt	71,975		75,431
Other Debt Obligations
Debt Instrument [Line Items]
Total long-term Debt	$ 11,252		$ 0

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Details) - USD ($)			3 Months Ended		9 Months Ended
	Oct. 27, 2022	May 13, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Debt Instrument [Line Items]
Loss on early extinguishment of debt					$ (19,219,000)	$ (28,955,000)
Net investment hedge (losses) gains			$ 0	$ 0	0	5,110,000
Proceeds from borrowings of long-term debt and credit agreements					1,964,216,000	0
Repayments of borrowings from credit agreements					455,000,000	1,173,823,000
Interest Expense
Debt Instrument [Line Items]
Loss on early extinguishment of debt					$ 19,200,000	$ 29,000,000
1.875% Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate			1.875%		1.875%
2019 Credit Facility
Debt Instrument [Line Items]
Interest rate on amount borrowed					1.125%
2018 Credit Facility | Subsequent Event
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,500,000,000
Debt Instrument, Benchmark Rate Adjustment	0.10%
2018 Credit Facility | Subsequent Event | Minimum
Debt Instrument [Line Items]
Interest rate on amount borrowed	0.91%
2018 Credit Facility | Subsequent Event | Maximum
Debt Instrument [Line Items]
Interest rate on amount borrowed	1.375%
Unsecured debt | 1.125% Notes
Debt Instrument [Line Items]
Debt instrument, interest rate			1.125%		1.125%		1.125%
Credit facilities
Debt Instrument [Line Items]
Proceeds from borrowings of long-term debt and credit agreements					$ 250,000,000
Repayments of borrowings from credit agreements					$ 250,000,000
Senior notes | 3.45% Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate			3.45%		3.45%		3.45%
Senior notes | Four Point Six Five Percent Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate		4.65%	4.65%		4.65%		4.65%
Debt Instrument, Interest Rate, Effective Percentage		4.84%
Senior notes | Five Point Six Five Percent Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate		5.65%	5.65%		5.65%		5.65%
Debt Instrument, Interest Rate, Effective Percentage		5.71%
Senior notes | Five Point Zero Five Percent Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate		5.05%	5.05%		5.05%		5.05%
Debt Instrument, Interest Rate, Effective Percentage		5.18%
Senior notes | 4.15% Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate			4.15%		4.15%		4.15%
Repayments of borrowings from credit agreements					$ 425,000,000
Four Point Six Five Percent Senior Notes
Debt Instrument [Line Items]
Proceeds from borrowings of long-term debt and credit agreements		$ 650,000,000
Five Point Zero Five Percent Senior Notes
Debt Instrument [Line Items]
Proceeds from borrowings of long-term debt and credit agreements		600,000,000
Five Point Six Five Percent Senior Notes
Debt Instrument [Line Items]
Proceeds from borrowings of long-term debt and credit agreements		$ 450,000,000

Commitments and Contingencies -

Commitments and Contingencies - Activity in Recorded Environmental Liabilities (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Accrual for Environmental Loss Contingencies [Roll Forward]
Balance at beginning of period	$ 46,617
Expenditures	(2,495)
Accretion of discount	777
Accrual for Environmental Loss Contingencies, Period Increase (Decrease)	2,811
Foreign currency translation adjustments and other	(3,533)
Balance at end of period	44,177
Less amounts reported in Accrued expenses	9,496
Amounts reported in Other noncurrent liabilities	$ 34,681

Commitments and Contingencies_2

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended	9 Months Ended
	Oct. 28, 2021	May 31, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Loss Contingencies [Line Items]
Environmental remediation liabilities - discounted				$ 37,300		$ 39,700
Accrual for environmental loss contingencies - weighted-average discount rate				3.50%		3.50%
Environmental remediation liabilities - undiscounted				$ 65,200		$ 70,000
Potential revision on future environmental remediation costs before tax				9,000
Loss Contingency, Estimate of Possible Loss	$ 600,000
Litigation Settlement, Expense	$ 665,000
Payments for Legal Settlements		$ 332,500
Loss Contingency, Loss in Period			$ 657,412		$ 657,412
Loss Contingencies, Loss in Period, Net of Tax			$ 504,500		$ 504,500
Other noncurrent liabilities
Loss Contingencies [Line Items]
Tax Indemnification Liability				$ 55,800		$ 66,800

Leases - Additional Information

Leases - Additional Information (Details)	Sep. 30, 2022
Minimum
Lessee, Lease, Description [Line Items]
Lease renewal term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Lease renewal term	50 years
Real estate | Minimum
Lessee, Lease, Description [Line Items]
Lease term of contract	1 year
Real estate | Maximum
Lessee, Lease, Description [Line Items]
Lease term of contract	30 years
Non-real estate | Minimum
Lessee, Lease, Description [Line Items]
Lease term of contract	2 years
Non-real estate | Maximum
Lessee, Lease, Description [Line Items]
Lease term of contract	15 years

Leases - Leases Cost (Details)

Leases - Leases Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Operating lease cost	$ 11,456	$ 13,807	$ 32,657	$ 32,954
Amortization of right of use assets	952	153	2,354	466
Interest on lease liabilities	826	722	2,519	2,229
Total finance lease cost	1,778	875	4,873	2,695
Short-term lease cost	4,171	2,949	10,141	7,729
Variable lease cost	3,179	2,441	5,810	6,619
Total lease cost	$ 20,584	$ 20,072	$ 53,481	$ 49,997

Leases - Leases Cash Flow (Deta

Leases - Leases Cash Flow (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Operating cash flows from operating leases	$ 27,201	$ 24,462
Operating cash flows from finance leases	2,360	1,295
Financing cash flows from finance leases	999	471
Right-of-use asset obtained in exchange for operating leases	$ 8,378	$ 57,136

Leases - Leases Balance Sheet (

Leases - Leases Balance Sheet (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Leases [Abstract]
Other assets	$ 130,257	$ 154,741
Accrued expenses	30,039	31,603
Other noncurrent liabilities	102,198	126,997
Total operating lease liabilities	132,237	158,600
Net property, plant and equipment	70,968	75,302
Current portion of long-term debt(a)	3,723	3,768
Long-term debt	70,758	74,011
Total finance lease liabilities	$ 74,481	$ 77,779
Weighted average remaining lease term, operating leases	13 years 8 months 12 days	12 years 10 months 24 days
Weighted average remaining lease term, finance leases	24 years 6 months	24 years 6 months
Weighted average discount rate, operating leases, percent	3.60%	3.44%
Weighted average discount rate, finance leases, percent	4.41%	4.47%

Leases - Leases Maturity Table

Leases - Leases Maturity Table (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Operating Leases
Remainder of 2022	$ 9,376
2021	33,845
2022	21,552
2023	12,328
2024	9,977
Thereafter	121,460
Total lease payments	208,538
Less imputed interest	76,301
Total operating lease liabilities	132,237	$ 158,600
Finance Leases
Remainder of 2022	1,470
2021	5,879
2022	5,879
2023	5,879
2024	5,303
Thereafter	96,580
Total lease payments	120,990
Less imputed interest	46,509
Total finance lease liabilities	$ 74,481	$ 77,779

Segment Information - Additiona

Segment Information - Additional Information (Details) - segment	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2023
Segment Reporting Information [Line Items]
Number of reportable segments	3
Subsequent Event
Segment Reporting Information [Line Items]
Number of reportable segments		3

Segment Information - Summarize

Segment Information - Summarized Financial Information by Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Net sales	$ 2,091,805	$ 830,566	$ 4,699,126	$ 2,433,753
Adjusted EBITDA	1,189,966	217,569	2,232,105	642,251
Net income attributable to Albemarle Corporation	897,215	(392,781)	1,557,371	127,496
Depreciation and amortization	77,713	62,082	215,280	185,765
Acquisition and integration related costs	2,145	1,553	9,244	5,629
Interest and financing expenses	29,691	5,136	98,934	56,170
Income tax expense (benefit)	196,938	(114,670)	366,486	14,422
Non-operating pension and OPEB items	(5,027)	(5,471)	(15,345)	(16,407)
Loss Contingency, Loss in Period		657,412		657,412
Other	(8,709)	2,570	(8,265)	17,894
Restructuring and other		754		2,294
(Gain) loss on sale of business/interest in properties	0	984	8,400	(428,424)
Charitable Contribution Expense				20,000
All Other
Segment Reporting Information [Line Items]
Net sales	0	0	0	75,095
Adjusted EBITDA	0	0	0	29,858
Net income attributable to Albemarle Corporation	0	0	0	27,988
Depreciation and amortization	0	0	0	1,870
Acquisition and integration related costs	0	0	0	0
Interest and financing expenses	0	0	0	0
Income tax expense (benefit)	0	0	0	0
Non-operating pension and OPEB items	0	0	0	0
Loss Contingency, Loss in Period		0		0
Other	0	0	0	0
Restructuring and other		0		0
(Gain) loss on sale of business/interest in properties		0	0	0
Charitable Contribution Expense				0
Corporate
Segment Reporting Information [Line Items]
Adjusted EBITDA			(86,173)	(81,892)
Net income attributable to Albemarle Corporation			(540,184)	(414,856)
Depreciation and amortization			8,042	8,415
Acquisition and integration related costs			9,244	5,629
Interest and financing expenses			98,934	56,170
Income tax expense (benefit)			366,486	14,422
Non-operating pension and OPEB items			(15,345)	(16,407)
Loss Contingency, Loss in Period		657,412		657,412
Other			(13,350)	13,453
Restructuring and other				2,294
Reportable Segments | Lithium
Segment Reporting Information [Line Items]
Net sales	1,501,073	359,229	2,942,861	958,539
Adjusted EBITDA	1,111,243	125,416	1,915,066	341,293
Net income attributable to Albemarle Corporation	1,063,426	92,449	1,777,214	237,293
Depreciation and amortization	47,758	34,256	128,786	99,559
Acquisition and integration related costs	0	0	0	0
Interest and financing expenses	0	0	0	0
Income tax expense (benefit)	0	0	0	0
Non-operating pension and OPEB items	0	0	0	0
Loss Contingency, Loss in Period		0		0
Other	59	(1,289)	666	4,441
Restructuring and other		0		0
(Gain) loss on sale of business/interest in properties		0	8,400	0
Charitable Contribution Expense				0
Reportable Segments | Bromine
Segment Reporting Information [Line Items]
Net sales	354,908	277,783	1,092,239	837,978
Adjusted EBITDA	106,958	86,012	371,875	273,298
Net income attributable to Albemarle Corporation	93,186	73,409	332,208	235,670
Depreciation and amortization	13,772	12,603	39,667	37,628
Acquisition and integration related costs	0	0	0	0
Interest and financing expenses	0	0	0	0
Income tax expense (benefit)	0	0	0	0
Non-operating pension and OPEB items	0	0	0	0
Loss Contingency, Loss in Period		0		0
Other	0	0	0	0
Restructuring and other		0		0
(Gain) loss on sale of business/interest in properties		0	0	0
Charitable Contribution Expense				0
Reportable Segments | Catalysts
Segment Reporting Information [Line Items]
Net sales	235,824	193,554	664,026	562,141
Adjusted EBITDA	4,635	33,103	31,337	79,694
Net income attributable to Albemarle Corporation	(12,473)	20,039	(11,867)	41,401
Depreciation and amortization	12,689	13,064	38,785	38,293
Acquisition and integration related costs	0	0	0	0
Interest and financing expenses	0	0	0	0
Income tax expense (benefit)	0	0	0	0
Non-operating pension and OPEB items	0	0	0	0
Loss Contingency, Loss in Period		0		0
Other	4,419	0	4,419	0
Restructuring and other		0		0
(Gain) loss on sale of business/interest in properties		0	0	0
Charitable Contribution Expense				0
Corporate
Segment Reporting Information [Line Items]
Adjusted EBITDA	(32,870)	(26,962)
Net income attributable to Albemarle Corporation	(246,924)	(578,678)
Depreciation and amortization	3,494	2,159
Acquisition and integration related costs	2,145	1,553
Interest and financing expenses	29,691	5,136
Income tax expense (benefit)	196,938	(114,670)
Non-operating pension and OPEB items	(5,027)	(5,471)
Other	$ (13,187)	3,859
Restructuring and other		754
(Gain) loss on sale of business/interest in properties		$ 984	$ 0	(428,424)
Charitable Contribution Expense				$ 20,000

Segment Information - Summari_2

Segment Information - Summarized Financial Information by Reportable Segments (Footnote) (Details) - USD ($) $ in Thousands			3 Months Ended		9 Months Ended
	Oct. 28, 2021	Oct. 31, 2019	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Loss on early extinguishment of debt					$ (19,219)	$ (28,955)
Interest and Debt Expense			$ (29,691)	$ (5,136)	(98,934)	(56,170)
Litigation Settlement, Expense	$ 665,000
Accrual for Environmental Loss Contingencies, Period Increase (Decrease)					2,811
Revision of Prior Period, Error Correction, Adjustment
Segment Reporting Information [Line Items]
Interest and Debt Expense					$ 17,500
Lithium Hydroxide Conversion Assets
Segment Reporting Information [Line Items]
Ownership percentage		40%			40%
Interest Expense
Segment Reporting Information [Line Items]
Loss on early extinguishment of debt					$ 19,200	29,000
Cost of goods sold
Segment Reporting Information [Line Items]
Litigation Settlement, Expense					500
Retention Payment Expense			2,700		2,700
Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Other Restructuring Costs			1,300		3,200
Gain on sale of idle properties					4,300
Accrual for Environmental Loss Contingencies, Period Increase (Decrease)					2,800	1,600
Gain (Loss) on Disposition of Property Plant Equipment						4,000
Non-routine Chilean labor costs				2,500		8,600
Retention Payment Expense			1,900		1,900
Other Expense
Segment Reporting Information [Line Items]
Proceeds from Legal Settlements					600
Revision of tax indemnification expense			1,100	$ 100	1,100
Asset Retirement Obligation, Liabilities Incurred						$ 3,700
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount			10,600		10,600
Reversal of Divestiture Liability			$ 3,000		$ 3,000

Pension Plans and Other Postr_3

Pension Plans and Other Postretirement Benefits - Domestic and Foreign Pension and Postretirement Defined Benefit Plans (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Defined Benefit Plan Disclosure [Line Items]
Total net pension and postretirement benefits credit	$ (4,026)	$ (3,986)	$ (12,299)	$ (12,451)
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	959	1,425	2,914	3,776
Interest cost	5,530	5,113	16,703	15,352
Expected return on assets	(10,884)	(10,893)	(33,028)	(32,687)
Amortization of prior service benefit	21	29	68	87
Total net pension and postretirement benefits credit	(4,374)	(4,326)	(13,343)	(13,472)
Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	21	31	64	93
Interest cost	327	309	980	928
Total net pension and postretirement benefits credit	$ 348	$ 340	$ 1,044	$ 1,021

Pension Plans and Other Postr_4

Pension Plans and Other Postretirement Benefits - Pension and Postretirement Plan Contributions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Retirement Benefits [Abstract]
Employer contributions	$ 2.5	$ 3.2	$ 8.9	$ 22.1
Payment for other postretirement benefits	$ 0.7	$ 0.7	$ 2.1	$ 2.1

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Fair Value of Long-Term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Total long-term debt, excluding debt issuance costs	$ 3,393,136	$ 2,405,021
Total long-term debt, fair value, excluding debt issuance costs	$ 3,091,805	$ 2,593,590

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Fair Value, Option, Quantitative Disclosures [Line Items]
Foreign currency forward contracts, assets	$ 4,968		$ 4,968		$ 3,138
Foreign currency forward contracts, liabilities	9,219		9,219		305
Recognized gains (losses) of foreign currency forward contracts designated as hedging instruments	(9,652)	$ 214	(8,144)	$ (563)
Forward contracts | Other, net
Fair Value, Option, Quantitative Disclosures [Line Items]
Derivative, Cash Received on Hedge			(38,600)
Cash settlements				800
Designated as Hedging Instrument | Forward contracts
Fair Value, Option, Quantitative Disclosures [Line Items]
Derivative, notional amount	101,600		101,600		36,500
Fair value foreign currency forward contracts designated as hedging instruments, asset	0		0		237
Fair value foreign currency forward contracts designated as hedging instruments, liabilities	9,169		9,169		57
Recognized gains (losses) of foreign currency forward contracts designated as hedging instruments	(9,653)	214	(8,144)	(563)
Designated as Hedging Instrument | Forward contracts | Other current assets
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value foreign currency forward contracts designated as hedging instruments, asset	0		0		237
Designated as Hedging Instrument | Forward contracts | Accrued expenses
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value foreign currency forward contracts designated as hedging instruments, liabilities	9,169		9,169		57
Not Designated as Hedging Instrument | Forward contracts
Fair Value, Option, Quantitative Disclosures [Line Items]
Derivative, notional amount	2,057,700		2,057,700		618,100
Fair value foreign currency forward contracts not designated as hedging instruments, asset	4,968		4,968		2,901
Fair value foreign currency forward contracts not designated as hedging instruments, liabilities	50		50		248
Not Designated as Hedging Instrument | Forward contracts | Other current assets
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value foreign currency forward contracts not designated as hedging instruments, asset	4,968		4,968		2,901
Not Designated as Hedging Instrument | Forward contracts | Accrued expenses
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value foreign currency forward contracts not designated as hedging instruments, liabilities	50		50		$ 248
Not Designated as Hedging Instrument | Forward contracts | Other (expenses) income, net
Fair Value, Option, Quantitative Disclosures [Line Items]
Recognized (losses) gains of foreign currency forward contracts not designated as hedging instruments	$ (9,056)	$ (1,199)	$ (36,326)	$ 658

Fair Value Measurement (Details

Fair Value Measurement (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments under executive deferred compensation plan	$ 25,495	$ 32,491
Private equity securities	12,197
Private equity securities measured at net asset value	4,716	4,696
Foreign currency forward contracts, assets	4,968	3,138
Obligations under executive deferred compensation plan	25,495	32,491
Foreign currency forward contracts, liabilities	9,219	305
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	253,701	246,517
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	(2,368)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Accretion of Discount	9,552
Debt Securities, Available-for-sale	253,701	246,517
Quoted Prices in Active Markets for Identical Items (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments under executive deferred compensation plan	25,495	32,491
Private equity securities	12,197
Foreign currency forward contracts, assets	0	0
Obligations under executive deferred compensation plan	25,495	32,491
Foreign currency forward contracts, liabilities	0	0
Debt Securities, Available-for-sale	0	0
Quoted Prices in Active Markets for Similar Items (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments under executive deferred compensation plan	0	0
Private equity securities	0
Foreign currency forward contracts, assets	4,968	3,138
Obligations under executive deferred compensation plan	0	0
Foreign currency forward contracts, liabilities	9,219	305
Debt Securities, Available-for-sale	0	0
Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments under executive deferred compensation plan	0	0
Private equity securities	0
Foreign currency forward contracts, assets	0	0
Obligations under executive deferred compensation plan	0	0
Foreign currency forward contracts, liabilities	0	0
Debt Securities, Available-for-sale	$ 253,701	$ 246,517

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive (Loss) Income - Components and Activity in Accumulated Other Comprehensive (Loss) Income Net of Deferred Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Increase (Decrease) in Accumulated Other Comprehensive Income [Roll Forward]
Beginning Balance	$ 6,300,975	$ 6,365,771	$ 5,805,607	$ 4,468,594
Other comprehensive income (loss), before reclassifications	(210,190)	(39,081)	(332,431)	(42,376)
Amounts reclassified within accumulated other comprehensive loss				0
Amounts reclassified from accumulated other comprehensive loss	18	672	7,456	2,022
Total other comprehensive loss, net of tax	(210,172)	(38,409)	(324,975)	(40,354)
Other comprehensive (income) loss attributable to noncontrolling interests	1	(26)	116	50
Ending Balance	$ 6,964,627	5,895,232	$ 6,964,627	5,895,232
1.875% Senior Notes
Increase (Decrease) in Accumulated Other Comprehensive Income [Roll Forward]
Debt instrument, interest rate	1.875%		1.875%
4.15% Senior Notes | Senior notes
Increase (Decrease) in Accumulated Other Comprehensive Income [Roll Forward]
Debt instrument, interest rate	4.15%		4.15%		4.15%
Foreign Currency Translation and Other
Increase (Decrease) in Accumulated Other Comprehensive Income [Roll Forward]
Beginning Balance	$ (515,269)	(324,951)	$ (391,674)	(369,152)
Other comprehensive income (loss), before reclassifications	(200,538)	(39,295)	(324,287)	(46,923)
Amounts reclassified within accumulated other comprehensive loss				51,703
Amounts reclassified from accumulated other comprehensive loss	18	21	57	71
Total other comprehensive loss, net of tax	(200,520)	(39,274)	(324,230)	(46,852)
Other comprehensive (income) loss attributable to noncontrolling interests	1	(26)	116	50
Ending Balance	(715,788)	(364,251)	(715,788)	(364,251)
Net Investment Hedge
Increase (Decrease) in Accumulated Other Comprehensive Income [Roll Forward]
Beginning Balance	0	0	0	46,593
Other comprehensive income (loss), before reclassifications	0	0	0	5,110
Amounts reclassified within accumulated other comprehensive loss				(51,703)
Amounts reclassified from accumulated other comprehensive loss	0	0	0	0
Total other comprehensive loss, net of tax	0	0	0	5,110
Other comprehensive (income) loss attributable to noncontrolling interests	0	0	0	0
Ending Balance	0	0	0	0
Cash Flow Hedge
Increase (Decrease) in Accumulated Other Comprehensive Income [Roll Forward]
Beginning Balance	8,131	5,672	6,623	6,449
Other comprehensive income (loss), before reclassifications	(9,652)	214	(8,144)	(563)
Amounts reclassified within accumulated other comprehensive loss				0
Amounts reclassified from accumulated other comprehensive loss	0	0	0	0
Total other comprehensive loss, net of tax	(9,652)	214	(8,144)	(563)
Other comprehensive (income) loss attributable to noncontrolling interests	0	0	0	0
Ending Balance	(1,521)	5,886	(1,521)	5,886
Interest Rate Swap
Increase (Decrease) in Accumulated Other Comprehensive Income [Roll Forward]
Beginning Balance	0	(8,722)	(7,399)	(10,022)
Other comprehensive income (loss), before reclassifications	0	0	0	0
Amounts reclassified within accumulated other comprehensive loss				0
Amounts reclassified from accumulated other comprehensive loss	0	651	7,399	1,951
Total other comprehensive loss, net of tax	0	651	7,399	1,951
Other comprehensive (income) loss attributable to noncontrolling interests	0	0	0	0
Ending Balance	0	(8,071)	0	(8,071)
Accumulated Other Comprehensive (Loss) Income
Increase (Decrease) in Accumulated Other Comprehensive Income [Roll Forward]
Beginning Balance	(507,138)	(328,001)	(392,450)	(326,132)
Total other comprehensive loss, net of tax	(210,171)	(38,435)	(324,859)	(40,304)
Ending Balance	$ (717,309)	$ (366,436)	$ (717,309)	$ (366,436)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive (Loss) Income - Amount of Income Tax Benefit (Expense) Allocated to Component of Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Accumulated Other Comprehensive (Loss) Income [Line Items]
Total other comprehensive loss, net of tax	$ (210,172)	$ (38,409)	$ (324,975)	$ (40,354)
Foreign Currency Translation and Other
Equity [Abstract]
Other comprehensive income (loss), before tax	(198,888)	(39,266)	(323,777)	(46,836)
Accumulated Other Comprehensive (Loss) Income [Line Items]
Other comprehensive income (loss), before tax	(198,888)	(39,266)	(323,777)	(46,836)
Income tax expense	(1,632)	(8)	(453)	(16)
Total other comprehensive loss, net of tax	(200,520)	(39,274)	(324,230)	(46,852)
Net Investment Hedge
Equity [Abstract]
Other comprehensive income (loss), before tax	0	0	0	6,552
Accumulated Other Comprehensive (Loss) Income [Line Items]
Other comprehensive income (loss), before tax	0	0	0	6,552
Income tax expense	0	0	0	(1,442)
Total other comprehensive loss, net of tax	0	0	0	5,110
Cash Flow Hedge
Equity [Abstract]
Other comprehensive income (loss), before tax	(9,652)	214	(8,144)	(563)
Accumulated Other Comprehensive (Loss) Income [Line Items]
Other comprehensive income (loss), before tax	(9,652)	214	(8,144)	(563)
Income tax expense	0	0	0	0
Total other comprehensive loss, net of tax	(9,652)	214	(8,144)	(563)
Interest Rate Swap
Equity [Abstract]
Other comprehensive income (loss), before tax	0	834	9,739	2,502
Accumulated Other Comprehensive (Loss) Income [Line Items]
Other comprehensive income (loss), before tax	0	834	9,739	2,502
Income tax expense	0	(183)	(2,340)	(551)
Total other comprehensive loss, net of tax	$ 0	$ 651	$ 7,399	$ 1,951

Related Party Transactions (Det

Related Party Transactions (Details) - Unconsolidated Affiliates - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Related Party Transaction [Line Items]
Sales to unconsolidated affiliates	$ 9,490	$ 5,629	$ 24,359	$ 16,357
Purchases from unconsolidated affiliates	614,889	$ 55,540	1,146,329	$ 144,461
Receivables from unconsolidated affiliates	3,301		3,301		$ 2,139
Payables to unconsolidated affiliates(a)	$ 554,845		$ 554,845		$ 47,499

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information - Schedule of supplemental information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Supplemental Cash Flow Information [Abstract]
Capital expenditures included in Accounts payable	$ 253,183	$ 157,743
Notes Issued	10,876	0
Non-cash proceeds from divestitures	$ 0	$ 244,530

Supplemental Cash Flow Inform_4

Supplemental Cash Flow Information - Additional Information (Details) - USD ($) $ in Thousands		9 Months Ended
	Oct. 31, 2019	Sep. 30, 2022	Sep. 30, 2021
Cash Flow Supplemental Disclosures [Line Items]
Non-cash transfer of 40% value of construction in progress of Kemerton plant to MRL		$ 115,969	$ 135,928
One Time Transition Tax, Reclassification		$ 42,500	28,700
Mineral Resources Limited Wodgina Project
Cash Flow Supplemental Disclosures [Line Items]
Ownership percentage	60%
Lithium Hydroxide Conversion Assets
Cash Flow Supplemental Disclosures [Line Items]
Ownership percentage	40%	40%
Lithium Hydroxide Conversion Assets | Mineral Resources Limited Wodgina Project
Cash Flow Supplemental Disclosures [Line Items]
Non-cash transfer of 40% value of construction in progress of Kemerton plant to MRL		$ 116,000	$ 135,900